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ABSTRACT 
This scientific report provides an overview of all research carried out on Schmallenberg virus (SBV), reviewing 
the current knowledge on SBV regarding genotyping findings, susceptible species, pathogenesis, transmission 
routes, immunity, seroprevalence, geographical and temporal SBV spread, improved within-herd transmission 
model, SBV impact assessment and within-herd and regional spread models. Metagenomic analysis identified 
SBV as a novel orthobunyavirus emerged in 2011 and it has been detected in domestic cattle, sheep, goats and 
12  wild  species.  Seroprevalence  studies  indicate  that  SBV  has  probably  spread  over  the  whole  of  Europe, 
showing high seroprevalence at national scale, while larger variability is observed at regional scales. Clinical 
disease frequency is low and experimental infection on pregnant ewes and cows suggest that SBV rarely induces 
malformations. SBV may be detected from semen with a low frequency though there is no scientific evidence of 
transmission through insemination. Vector competence studies suggest that Culicoides are likely to be able to 
transmit  SBV  but  found  no  evidence  that  mosquitoes  are  likely  to  be  able  to  transmit  it.  SBV  vertical 
transmission has not yet been identified as a major route. SBV has successfully overwintered, despite lengthy 
period of minimal vector activity and duration of immunity in cattle lasts for at least one year. A farm-to-farm 
spread model for SBV shows a rapid spread of infection across the study region and latent period, duration of 
viraemia, probability of transmission from host to vector and virus replication are sufficient to account for the 
rapid  SBV  spread.  The  between-farm  SBV  transmission  model  indicates  that  the  application  of  movement 
restrictions has little effect on SBV spread. An impact assessment based on limited data suggests a probable 
effect  of  SBV  infection  on  abortion,  short  gestation,  non-return  and  the  number  of  artificial  inseminations 
required per animal. International trade restrictions by third countries represent the main SBV impact. 
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SUMMARY 
This scientific report provides an overview of research carried out on Schmallenberg virus in the 
different Member States (MS), with special attention given to research co-financed by the European 
Commission, focusing in particular on three main research lines:  
  A review of the current knowledge of SBV regarding:  
-  Genetic analysis findings  
-  Susceptible species reported  
-  Pathogenesis, covering viraemic and susceptible periods  
-  Potential  transmission  routes,  discussing  horizontal,  vertical  and  vector-borne 
transmission as well as the ability of each to explain overwintering 
-  Duration of immunity  
-  Findings from seroprevalence studies conducted in different MS.  
  The use of transmission models to evaluate geographical as well as temporal spread of SBV, 
specifically: 
-  a within-farm transmission model using the large scale seroprevalence studies from 
Belgium and the Netherlands to estimate within-herd transmission parameters 
-  a  network  model  describing  regional  spread  and  the  potential  impact  of  animal 
movement restrictions SBV spread 
-  A  modified  continental  spread  model  similar  to  that  presented  in  the  previous 
scientific report but exploring a broader range of possible transmission kernels.  
  Summarizing SBV impact assessment carried out in several MS.  
Metagenomic analysis of animal material allowed the rapid identification of SBV, a newly discovered 
orthobunyavirus  related  to  viruses  in  the  Simbu  serogroup,  as  the  cause  of  the  new  disease  that 
emerged in 2011. The availability of the (almost) complete nucleotide sequence of the SBV genome 
enabled a PCR test for SBV to be developed and distributed throughout Europe. It also contributes to 
the  establishment  of  reverse  genetic  systems  (Elliott  et.  al.,  2013;  Varela  et.  al.,  2013)  that  will 
facilitate further research on SBV molecular biology, pathogenesis and vaccine development. The 
genome sequencing also highlighted the need for wide-scale sequencing studies on orthobunyaviruses 
in general as this would have helped to more quickly understand the relationship between SBV and 
extant Simbu serogroup viruses as well as the origin of SBV.  
SBV RNA or antibodies have been detected in domestic cattle, sheep and goats and also in another 12 
wild species: Alpacas, Anatolian water buffalo, Elk, Bison, Red deer, Fallow deer, Roe deer, Sika 
deer, Muntjac, Chamois, Wild boar and Dogs, as well as in 19 zoo species. The seroprevalence studies 
in cattle, sheep and goats indicate that SBV has probably spread over the whole of Europe. According 
to the seroprevalence studies conducted at national scale, prevalence at animal and herd levels were in 
general high, while for the regional studies a larger variability was observed. 
The number of herds with SBV confirmed AHS (arthrogryposis hydranencephaly syndrome) cases 
compared to the level of infection indicated by seroprevalence studies, suggest that the frequency of 
clinical disease is low. SBV induces malformed calves only in a very limited number of cases, as 
demonstrated by experimental infection studies on pregnant cows and ewes. Although these resulted in 
only one malformed calf out of a total of 24 foetuses from a cow inoculated at day 90 of pregnancy, 
the presence of viral RNA could be demonstrated in the placenta of some ewes. The proportion of 
positive  placenta  and  foetuses  was  higher in  the  group  of  ewes  infected  at  day  45  of  pregnancy 
compared to the ewes infected at day 38 of pregnancy in one experiment and at day 60 compared to 
day 45 in the other experiment. From these studies it can be concluded that SBV infection leads only 
in a very limited number of cases to malformation even when the experimental infection is performed 
during the susceptible period.  
Limited numbers of articles have studied the risks of transmission of these viruses via semen and 
embryos. Recent data indicate that SBV may be detected in semen samples with a low frequency (< Schmallenberg virus: State of Art 
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6 %).  However,  there  is  no  scientific  evidence  of  transmission  through  insemination.  This  is  in 
agreement with epidemiological data, indicating that the vector transmission remains the principal 
route explaining the dissemination of such viruses. Details are given below.  
Phylogenetic relations of SBV with viruses of the Simbu serogroup led to suspicion that SBV was 
transmitted by Culicoides. Following detection of the SBV incursion, vector competence assays were 
performed on colonized mosquitoes and both colonized and field collected Culicoides (Veronesi et. 
al., 2013b; Balenghien et. al., 2014). These studies confirmed that several Culicoides species are likely 
to be capable of transmitting SBV but provided no evidence that the mosquito species studied are 
likely to be able to act as vectors. Viral RNA presence was also assessed in field collected Culicoides 
from farms in the affected regions. Studies in Belgium, Netherlands and France (De Regge et. al., 
2012; Elbers et. al., 2013a; Balenghien et. al., 2014) also suggest a high probability that C. obsoletus, 
C.  scoticus  and  C.  chiopterus  have  a  role  as  vectors  of  SBV in  northern  Europe.  C.  dewulfi,  C. 
pulicaris, C. nubeculosus and C. punctatus have also been implicated as suspected vectors in Belgium, 
France or Poland (De Regge et. al., 2012; Larska et. al., 2013; Balenghien et. al., 2014), although 
quantities  of  SBV  RNA  detected  were  equivocal  in  defining  the  level  of  dissemination  that  had 
occurred (Veronesi et. al., 2013b). Studies of C. imicola in Sardinia failed to convincingly implicate 
this species in SBV transmission (Balenghien et. al., 2014). Vector competence studies currently being 
conducted in Italy will indicate the competence of C. imicola for SBV. Taken in their entirety, these 
studies  convincingly  implicated  a  range  of  widespread  and  abundant  farm-associated  Culicoides 
species in the transmission of SBV, including at least the species C. obsoletus, C. scoticus and C. 
chiopterus. 
There is no evidence yet that vertical transmission is a major route of transmission of SBV. SBV has 
been detected in certain tissues of clinically-affected newborn calves, kids and lambs but neither SBV 
virus  nor  RNA  has  been  documented  in  their  blood.  There  is  therefore  currently  no  evidence  to 
suggest that clinically affected newborns represent a viable source of virus for vectors. There is limited 
evidence for the transmission of SBV to progeny Culicoides.  
SBV has successfully overwintered, despite lengthy period of minimal vector activity. The mechanism 
is unknown at present; however vertical transmission in host or vector may play a role. Evidence of 
persistent infection in the host has not been yet documented. 
There are only limited data on duration of immunity in cattle and none on the duration of immunity in 
sheep. The data for cattle suggest that immunity lasts for at least one year following natural infection. 
Data on immunity over longer periods is not yet available. 
A model for the farm to farm spread of a vector-borne virus parameterized for SBV show a rapid 
spread of infection across the study region. Changes to four epidemiological parameters (latent period, 
duration  of  viraemia,  probability  of  transmission  from  host  to  vector  and  virus  replication)  are 
sufficient to account for the rapid SBV spread within and between farms relative to that seen for BTV-
8.  This  suggests  that  alternative  transmission  mechanisms  (for  example,  direct  transmission  or 
additional vector species) are not necessary to explain the observed patterns of spread of SBV, though 
they may still play a minor role. The enhanced between-farm transmission of SBV brought about by 
these  four  parameters  is  such  that  the  application  of  movement  restrictions,  even  a  total  animal 
movement ban, would have little effect on the spread of SBV (relative reduction around 4 %).  
The ability to estimate impact of Schmallenberg virus was restricted by the limited availability of data; 
studies conducted reported a probable effect of SBV infection on abortion, shorter gestation, non-
return and the number of artificial inseminations required per animal. The principle economic impact 
of SBV has been felt via international trade restrictions, particularly in live animals and semen. Cattle 
semen trade has been restricted in several countries, in terms of percentage of total semen trade, most 
of the trades happens within the EU (2010: 73.4 % and 2011: 82.8 %). For the semen trade outside of 
the EU (2010: 26.6 % and 2011: 17.2 %), around 60 % of those are trade with countries imposing 
restrictions, representing for 2010 a 15.1 % of the total EU semen trade and for 2011 10.9 %. A 
decline between 11 and 26 % of the semen doses have been observed from previous years compared to 
2012, as for the pure-bred breeding animals, the export value dropped 20 % in 2012 with respect to 
2011 (http://www.adt.de/expla_fr.html). Schmallenberg virus: State of Art 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The previous request sent to EFSA with reference SANCO/G2/FR/Ip (2012) 97796 re for technical 
assistance on Schmallenberg virus (SBV).  
The  reports  issued  by  EFSA  were  commended  in  several  occasions  by  the  Commission  and  the 
Member  States  for  their  quality  and  timeliness.  The  Commission  would  like  to  convey  the 
appreciation of the work done by EFSA‟s services and would like to state that the EU needs further 
support by EFSA in this matter.  
The  Commission  and  the  Member  States  recognise  the  importance  for  the  EU  to  continue  in  its 
transparency policy and EFSA has a major role to play in this respect.  
The Commission wishes that EFSA provides regular updates, becoming de facto the showcase for the 
entire world on the evolution of the epidemiological situation on SBV in the EU.  
Therefore, in the context of Article 31 of Regulation (EC) No. 178/2002, EFSA has been asked to 
continue providing scientific assistance to the Commission. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested to deliver: 
1.  Continue to collect data through the EFSA Data Collection Framework (DCF) from Member 
States in a structured manner in coordination with DG SANCO. This should allow for updates 
of EFSA reports (three times per year) on the description of the epidemiological situation of 
SBV  in  the  EU.  This  needs  to  be  done  keeping  the  possibility  to  use  it  for  further  risk 
assessment. A first update should be produced by 15 November 2012. A second report on 
31/5/2013 and a third on 1/12/13. 
2.  An update of the report on the overall assessment of the impact of this infection on animal 
health,  animal  production  and  animal  welfare.  The  intent  would  be  to  fill  the  data  gaps 
identified in the EFSA May 2012 report and to allow for completing the assessment of the 
impact, specially the within-herd impact. The report should also take in account the latest 
scientific  findings  on  SBV,  especially  studies  co-financed  by  the  EU
4  providing  a 
comprehensive report on the state of art of the scientific knowledge. Notably this should track 
the research initiatives going on in several Member States, with a note of attention for the new 
data to be provided on the traded commodities and their risk of transmitting the infection. A 
report should be produced by 1 December 2013. 
CONTEXT OF THE SCIENTIFIC OUTPUT 
This scientific report provides a state of art summary description of the research conducted on SBV in 
the different MS. It also provides a re-assessment of SBV spread model parameters, as well as an 
alternative model to assess potential effect of animal movement restrictions as control measures. 
The scientific provides summaries regarding three main research outputs concerning SBV in Europe to 
answer TOR 2: 
  A review of the current knowledge on SBV regarding: 
o  Genetic analysis findings  o  Transmission routes 
o  Susceptible species reported  o  Immunity 
o  Pathogenesis  o  Seroprevalence studies 
 
  Geographical and temporal spread of SBV: 
o  Fine tuning within herd transmission parameters 
o  A network model to describe regional spread 
o  Continental spread model revisited 
  Summary of SBV impact assessment carried out in several Member States  
                                                       
4  Commission Implementing Decision 2012/349/EU Schmallenberg virus: State of Art 
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RESEARCH FINDINGS: SCHMALLENBERG STATE OF ART 
1.  Schmallenberg Virus - Genotyping Findings 
1.1.  Genetic Analysis of SBV 
More than 170 named virus isolates comprise the genus Orthobunyavirus in the family Bunyaviridae. 
Distinguishing features of orthobunyaviruses are the pattern of sizes of genomic RNA segments, the 
pattern of sizes of the structural proteins and the consensus nucleotide sequences at the 3‟ and 5‟ 
termini of the viral RNA segments (Elliott and Blakqori, 2011). Orthobunyaviruses are conveniently 
divided  into  18  serogroups  on  the  basis  of  complement  fixation  (CF),  neutralisation  (NT)  and 
haemagglutination  inhibition  (HI)  assays.  While  this  serological  classification  of  viruses  proved 
convenient, it did produce anomalies due to the propensity for genome segment reassortment, where 
different serological tests reflected antigenic relationships of proteins encoded by different genome 
segments e.g. CF is mediated by the S segment-encoded nucleocapsid protein whereas NT and HI 
antibodies are directed against the M segment encoded glycoproteins. The International Committee for 
the Taxonomy of Viruses has defined 48 species with the Orthobunyavirus genus (Plyusnin et. al., 
2012) (In virus taxonomy, a species is described as “a monophyletic group of viruses whose properties 
can  be  distinguished  from  those  of  other  species  by  multiple  criteria”; 
http://www.ictvonline.org/codeOfVirusClassification.asp).  For  orthobunyaviruses,  species 
demarcation is based on serological criteria (cross-NT and cross-HI tests), the inability of one species 
to genetically reassort with another species, and that the amino acid sequences of the nucleocapsid 
protein of different species differ by more than 10 %, but such classification has to be considered fluid 
due the general paucity of molecular details of most orthobunyaviruses.  
According to the ICTV, a virus belongs to a serogroup if it cross-reacts with members of that group by 
one or more serological tests (Nichol et. al., 2005). Previous studies of Simbu group viruses have 
demonstrated extensive cross reactivity through CF tests. 
The identification of SBV was based on metagenomic analysis of pooled blood samples from acute 
infected cattle; comparison of the obtained sequences indicated that the closest relatives were viruses 
in the Simbu serogroup (Hoffmann et. al., 2012). The Simbu serogroup contains 23 viruses that have 
been divided among 8 species (Table 1.1), some of which are associated with disease in ruminants, 
while Oropouche virus causes a severe febrile illness in man. Based on the available sequences in the 
database at that time, SBV sequences showed 69 % identity with Akabane virus L segment, 71 % 
identity with Aino virus M segment and 97 % identity with Shamonda virus S segment (Hoffmann et. 
al., 2012). When sequences of more Simbu group viruses were determined, it was reported that the M 
segment of the Sathuperi and Douglas orthobunyaviruses displayed higher identity with SBV whereas 
the S and L segments were closer to Shamonda virus, suggesting that SBV was a reassortant virus 
between Sathuperi and Shamonda viruses (Yanase et. al., 2012).  
Subsequently, near complete genome sequences were determined for Aino, Douglas, Peaton, Sabo, 
Sango, Sathuperi, Shamonda, Shuni, and Simbu viruses. Phylogenetic analysis of these sequences 
suggested  SBV  belongs  to  the  Sathuperi  virus  species,  and  further  that  SBV  is  an  ancestor  of 
Shamonda virus, which in turn is a reassortant containing the S and L segments from SBV and the M 
segment from an unknown virus (Goller et. al., 2012). In addition, it was shown that anti-SBV serum 
neutralised Douglas and Sathuperi viruses, but not Shamonda virus. While these studies have further 
defined the relationship of SBV to other Simbu serogroup viruses, they do not help in identifying the 
origin of SBV. Future research requires more nucleotide sequence analysis of the remaining Simbu 
serogroup viruses and of other isolates of these viruses from different geographical locations. 
   Schmallenberg virus: State of Art 
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Table 1.1: Simbu serogroup viruses. 
Species  Virus  Distribution  Clinical Signs  Principal 
Arthropod 
Vector 
Akabane 
Akabane  Africa,  Asia, 
Australia 
+  Mosquitoes, 
Culicoides spp. 
Sabo  Africa    Culicoides spp. 
Tinaroo  Australia    Culicoides spp. 
Yaba-7  Africa    ? 
Manzanilla 
Manzanilla  S America    ? 
Buttonwillow  N America    Culicoides spp. 
Ingwavuma  Africa, Asia  +  mosquitoes 
Inini  S America    ? 
Mermet  N America    mosquitoes 
Oropouche 
Oropouche  S America    Culicoides spp, 
mosquitoes 
Facey‟s Paddock  Australia    ? 
Utinga  S America    ? 
Utive  S America    ? 
Sathuperi 
Sathuperi  Africa, Asia   +  Culicoides spp, 
mosquitoes 
Douglas  Australia    Culicoides spp. 
Simbu  Simbu  Africa    mosquitoes 
Shamonda 
Shamonda  Africa, Asia  +  Culicoides spp. 
Peaton  Australia  +  Culicoides spp. 
Sango  Africa  +  Culicoides spp, 
mosquitoes 
Shuni 
Shuni  Africa    Culicoides spp. 
mosquitoes 
Aino  Asia, Australia  +  Mosquitoes, 
Culicoides spp. 
Kaikalur  Asia, Australia    mosquitoes 
Thimiri  Thimiri  Africa, Asia    ? 
  
It is not known how SBV was introduced into Europe. One hypothesis is that the introduction of SBV, 
and indeed other viruses such as BTV 8, could be via infected Culicoides transported into Europe. In 
this regard, detection, isolation and characterisation of Simbu serogroup viruses in other regions in the 
world are needed to determine whether a virus closely related to SBV circulates in a particular region. 
This would be a starting point to investigate possible routes of introduction. On the other hand in 
Turkey,  Azkur  et.  al.,  (2013)  reported  that  antibodies  to  SBV  were  detected  in  serum  samples 
collected from slaughterhouses between 2006 and 2013, suggesting that SBV (or a similar virus) may 
have been present before its first detection in Germany. However, these authors used an commercial 
ELISA  which  recognise  also  antibodies  against  other  orthobunyaviruses  and  they  did  not  further 
analyse the positive samples in seroneutralisation assay for confirmation. Further characterisation of 
these samples is needed. 
1.2.  Evolution of SBV 
Bunyaviruses can evolve through two mechanisms, the accumulation of mutations because the viral 
RNA-dependent RNA polymerase is known to be error-prone  as it lacks a proofreading ability, and 
genome  segment  re-assortment  which  results  in  more  dramatic  antigenic  changes.  Studies 
investigating SBV isolates have reported high levels of variability, especially in the M segment. , but 
no correlation was found between host and geographical location of the variants found (Hulst et. al., 
2013, Rosseel et. al., 2012). Two studies have reported a hypervariable mutation within the coding Schmallenberg virus: State of Art 
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sequence for the N-terminus of Gc glycoprotein, and have suggested that this may play a role in 
immune evasion (Coupeau et. al., 2013, Fischer et. al., 2013).  
Two inactivated SBV vaccines have been approved in Europe, Bovilis SBV (MSD Animal Health) 
and  SBVvax  (Merial),  which  are  reported  to  elicit  neutralising  antibodies  within  three  weeks  of 
inoculation though the duration of immunity has not been determined. The impact of genetic variation 
within  SBV  isolates  on  protection  by  these  two  vaccines  requires  assessment.  The  biological 
significance of hypervariable region in Gc (glycoprotein) also requires study, both in ruminants and in 
vector species.  
Reassortment  is restricted  to  closely  related  bunyaviruses,  and  even  then  certain  combinations  of 
viruses appear genetically incompatible. The lack of other Simbu serogroup viruses in Europe suggests 
that reassortment will not be of immediate concern. However, the introduction of another Simbu group 
virus  may  give  opportunity  of  reassortment  in the  future,  and  reassorted  bunyaviruses  have  been 
shown  to  have  different  vector  specificities  and  virulence  properties.  Enhanced  surveillance  is 
recommended.  
2.  Susceptible Species 
A susceptible species is an animal species that can support replication of an agent. A susceptible 
species could be an animal species in which infection by a disease agent has been demonstrated by 
natural cases or by experimental infection that mimics the natural pathways. A reservoir host is one in 
which an infectious agent normally lives and multiplies and is therefore a common source of infection 
to other animals (Thrushfield M. 1995)  
Regarding  SBV  and  the  identification  of  susceptible  species  the  information  available  can  be 
summarised in different categories: 
1.  Animal species where the agent (SBV) and clinical expression (either in adult animals or their 
offspring) of the disease have been demonstrated either by direct or indirect detection. 
a.  Animal species infected naturally: Domestic Cattle, Sheep, Goats  
b.  Animal species infected experimentally: Domestic Cattle, Sheep, Goats 
2.  Animal species where the infectious agent (SBV) has been detected (direct detection of the 
pathogen): Dog. 
3.  Animal  species  where  a  serological  reaction  to  the  agent  (SBV)  has  been  demonstrated 
(indirect detection of the pathogen): Alpacas, Anatolian water buffalo, Elk, Bison, Red deer, 
Fallow deer, Roe deer, Muntjac, Chamois, Dog 
The evidence available regarding species other than domestic cattle, sheep and goats is summarised in 
Annex B. Other species such as horses and llamas (EFSA, 2013a) have been tested but not confirmed 
by serological testing. 
The three publications related to SBV in domestic dogs present conflicting evidence. One is a case 
report of a seropositive dog with no clinical signs (Wensman et. al., 2013), a second reports detection 
of viral RNA by RT-PCR in the cerebellum of an animal showing neurological signs (Saileau et. al., 
2013) and the third (Garigliany et. al., 2013) reports the results of testing of a group of animals likely 
to have been exposed to the virus, but where only one tested inconclusive for SBV specific antibodies. 
With the available evidence it is impossible to draw definite conclusions regarding the susceptibility of 
domestic dogs to SBV infection. 
Experimental infections in pigs (Poskin et. al., 2014) and poultry (EC, 2014) have been performed and 
results indicate that virus replication does not occur in these species. Also, a study conducted on South 
American camelids (SAC) in Germany showed high seroprevalence at animal (62.4 %) and herds 
(92.4 %) levels, but no SVB-RNA was detected which might be linked to the short-time viraemia. 
Although 3 malformed SAC crias were reported, SBV infection could not be confirmed to be the 
cause of malformations. 
In addition, the role of wildlife was studied in Germany, France, the Netherlands and United Kingdom 
(EC, 2014), showing seropositive results for: Moufflons, Roe deer, Fallow deer, Red deer, Sika deer, Schmallenberg virus: State of Art 
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Wild boar. Moreover, samples from 38 different species in two zoos in United Kingdom were tested 
for SBV (using competitive ELISA) for which 19 resulted in seropositive results (Bongo, Babirusa, 
Banteng, Congo buffalo, European bison, Gaur, Gemsbok, Greater kudu, Grevy's zebra, Moose, Nile 
lechwe, Nubian goat, Onager, P.S. deer, Reindeer, Roan antelope, Scimitar-horned oryx, Sitatunga and 
Yak). These studies showed that horses, mice and wild carnivores might not play a role as reservoir in 
the epidemiology of SBV. 
3.  Pathogenesis 
3.1.  Viraemic Period 
When the first cases of acute Schmallenberg virus infections were observed, symptoms of milk drop, 
diarrhoea and fever were reported. Most of these symptoms were observed only during a short period 
(few days). These field observations of an apparently short viraemic period were confirmed by the first 
experimental  infections  conducted  by  the  researchers  of  FLI  (Hoffmann  et.  al.,  2012).  In  this 
experiment 2 calves were inoculated with blood samples originating from PCR positive cows for SBV 
(1 animal subcutaneously and 1 animal intravenously) and one calf with an on KC cell isolated SBV 
strains. Independent of the inoculation route, the inoculated animals became infected and had positive 
PCR  results  from  2–5  days  post  inoculation  and  one  animal  developed  fever  (a  temperature  of 
40.5 °C) four days post infection. 
Shortly after this first experiment, the same research group confirmed these first results after a second 
experimental infection study (Wernike et. al., 2013a) and nearly the same results were obtained: 2 
days after inoculation the animals became PCR-positive and stayed PCR-positive until 6 days post 
infection. 
Following the observations of Poskin et. al., 2014 there is no dose dependent difference in the duration 
and  level  of  RNAemia  after  experimental  infections  of  sheep.  These  authors  inoculated  different 
groups of sheep with different dilutions of SBV infectious serum and followed the RNAemia until 10 
days post inoculation. In contrast, the inoculation dose had an effect on the number of animals that 
became infected in each group. 
Although a short RNAamic period was observed after experimental inoculation of infectious serum, 
viral RNA could be detected in lymph nodes, particularly in the mesenteric lymph node, and spleen 
samples taken at autopsy. This viral RNA could be detected until 44 post-inoculation days of adults‟ 
sheep  indicating  a  possible  persistence  in  the  lymphoreticular  system  (Wernike  et.  al.,  2013b). 
Identical observations have been reported recently in cattle also (Wernike et. al., 2012 and Wernike et. 
al., 2013a) and sheep (Poskin et. al., 2014, paper accepted). It is not yet known if the presence of viral 
RNA in the lymphoreticular system plays a role in the pathogenesis of the virus. 
In contrast to the high similarity of results obtained after experimental infections of sheep and cattle, a 
slightly different RNAemia pattern was obtained from field observations. In a study conducted by 
Claine et. al., (2013) fifty female lambs born in autumn 2011 and January 2012 were investigated by 
analyzing bimonthly blood samples collected during April–October 2012. During this field trial, the 
SBV infection was observed by qPCR positive results around mid-July and ended in mid-October 
2012 and all of the animals became positive. Against all expectations, ten lambs tested positive in two 
samplings two weeks apart. This unexpected finding indicates that the duration of viraemia in sheep 
(assessed as positive RT-qPCR result) may be longer after natural SBV infection in comparison to 
experimental SBV infection in cattle and sheep. Unfortunately, these results are the only evidence 
about the viraemic period of SBV infections under field conditions. 
3.2.  Gestation Susceptible Periods 
Experimental  infections  of  pregnant  ewes  were  performed  at  CVI  Lelystad  and  CODA-CERVA 
Brussels and of pregnant cows at FLI Isle of Riems (EC, 2014). Inoculations of pregnant goats have 
been performed at ANSES and LNCR, Maisons-Alfort but these experiments are still on going. The Schmallenberg virus: State of Art 
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analyses of all data obtained from these experiments are till now not finished and no published data 
are available today. 
From the CVI experiment preliminary results were presented by N. Stockhofe-Zurwieden during the 
7th Epizone meeting (1st-4th of October 2013, Brussels), it was demonstrated that an SBV infection 
leads to infection of the placenta in most of the inoculated animals and a successive infection of the 
umbilical cord and the CNS in some of the foetuses (EC, 2014). The proportion of positive placentas 
was  higher  in  the  group  of  pregnant  ewes  inoculated  at  day  45  of  pregnancy  than  in  the  group 
inoculated at day 38. 
During  the  same  Epizone  meeting  FLI  presented  the  results  from  the  experimental  infection  of 
pregnant cows. Four groups of 6 pregnant cows were inoculated with SBV infectious serum at four 
different time points during pregnancy (day 60-90-120-150). One month after inoculation the cows 
were euthanized and samples of mother and foetus analysed. Only one foetus coming from a pregnant 
cow  inoculated  at  day  90  of  pregnancy  showed  arthrogryposis  and  torticollis.  The  first  results 
demonstrated a correlation between positivity found in the placenta and the foetus (EC, 2014). 
At CODA-CERVA the experimental infection study was performed on three groups: i) group 1 with 8 
ewes that were subcutaneously infected with infectious SBV serum at day 45 of gestation, ii) group 2 
with  9  ewes  that  were  infected  at  day  60  of  gestation  and  iii)  control  group  3  that  was  mock 
inoculated. Ewes were kept till the end of gestation. When signs of birth became apparent, colostrum 
was collected, the ewes were anesthetized and a caesarean section was performed. The lambs were 
assessed for malformations or other aberrant clinical signs and their capability to stand up and drink 
milk was evaluated. After euthanasia, blood and tissue samples were collected for further analysis.  
Only  one  lamb  was  born before the expected  date and  was in  good  health.  It  was able  to  drink 
colostrum from the mother and subsequently showed elevated anti-SBV antibody titters. Considering 
all groups in the study (control and infected groups) around 37 % of the lambs were dead at birth but 
showed no abnormalities (EC, 2014). All other lambs were born at term, no malformations were 
observed and they were able to stand up and showed a good suction reflex. No anti-SBV antibodies 
were detected in these lambs.  
When organ tissues from control ewes and their lambs were tested by PCR for the presence of the 
SBV-S segment, all samples were negative. In both the groups infected at 45 and 60 days of gestation, 
maternal tissues like placenta and cotyledons of some ewes were positive. All other organs of the ewes 
were SBV negative. Statistical analysis on the final results will have to show if there was a statistical 
difference between the numbers of ewes positive for maternal tissues in both groups. Of all samples 
tested from the lambs of the ewes infected at 45 days of gestation, only 1 umbilical cord was positive. 
All other organs were negative. Of all samples tested from the lambs of the ewes infected at day 60 of 
gestation, 3 were positive in some tissue. 
The results obtained from this experimental infection study demonstrate that infection of Mourerous 
sheep at day 45 and 60 of gestation did not induce malformations in the lambs and that only small 
amounts of SBV RNA could be found in some of the lambs at birth. Although a statistical results are 
not yet available, it seems that more positive samples were found in lambs originating from ewes that 
were infected at day 60 of gestation compared to day 45.  
No typical symptoms were reported in sheep after natural infections (Hoffmann et. al., 2012), although 
Wernike et. al., (2013b) reported one single sheep out of 13 RNAemic animals with clinical signs for 
several days after an experimental infection. 
From these studies it can be concluded that SBV infection leads only in a very limited number of cases 
to malformation (1 out of 24 fetuses) even when the experimental infection is performed during the 
period of susceptibility that the virus can reach the foetus (EC, 2014). Schmallenberg virus: State of Art 
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It is worth noting that other orthobunyaviruses have been associated with congenital defects in the 
offspring of ruminants. Just to mention a few, and without being exhaustive, it is known that Cache 
Valley virus (CVV), a member of the Bunyamwera serogroup, causes malformations in lambs in 
North America, and has also been associated with a few human cases, one of them fatal (de la Concha-
Bermejillo, 2003). Another member of the Bunyamwera serogroup found in the Americas, Main Drain 
virus, is associated with encephalomyelitis in horses, but also causes congenital malformations in 
experimentally inoculated pregnant ewes (Edwards et. al., 1997). 
4.  Transmission Routes  
4.1.  Vector Transmission: Role and Capacity to Spread the Disease 
Formal criteria to recognise a species as a vector have been defined by the World Health Organization 
(WHO 1961). These are: 
1)  recovery of virus from wild-caught specimens free from visible blood;  
2)  demonstration of ability to become infected by feeding on a viraemic vertebrate host or an 
artificial substitute;  
3)  demonstration of the ability to transmit biologically by bite;  
4)  accumulation  of  field  evidence  confirming  the  significant  association  of  the  infected 
arthropods  with  the  appropriate  vertebrate  population  in  which  disease  or  infection  is 
occurring. 
A given species that fulfils only one of the criteria can be considered a suspected vector. A species that 
passes the test of natural infection and experimental transmission can be considered a potential vector, 
whereas a species that fulfils all the conditions can be considered a confirmed vector (WHO 1967). 
Initial  phylogenetic  studies  placed  SBV  in  the  Simbu  serogroup,  sharing  a  close  relationship  to 
Sathuperi and Douglas viruses and secondarily to Shamonda virus and included in the same lineage as 
Akabane virus (Saeed, 2001; Goller, 2012, see section 1). These viruses have been primarily isolated 
from Culicoides (Table 1.1) (Doherty et. al., 1972; St George et. al., 1978; Lee 1979; Cybinski 1984; 
Blackburn et. al., 1985; Kurogi et. al., 1987; Yanase et. al., 2005) and more rarely from mosquitoes 
(Dandawate et. al., 1969; Metselaar et. al., 1976). Moreover, it has been demonstrated that Culicoides 
were efficient experimental vectors for Akabane virus (Jennings et. al., 1989), whereas attempts to 
demonstrate replication of this virus in mosquitoes have so far proved unsuccessful (Kay et. al., 1975). 
These findings and the recent emergence of the similarly Culicoides-borne bluetongue virus (BTV) in 
western and northern Europe (Mellor et. al., 2009a), therefore led to immediate suspicion that SBV 
was transmitted by Culicoides. Following detection of the SBV incursion, vector competence assays 
were performed on colonized mosquitoes and both colonized and field collected Culicoides (Veronesi 
et. al., 2013b; Balenghien et. al., 2014). Virus RNA presence was also assessed in field collected 
Culicoides from farms in the affected regions (De Regge et. al., 2012; Rasmussen et. al., 2012; Elbers 
et. al., 2013; Elbers et. al., 2013a; Goffredo et. al., 2013; Larska et. al., 2013; Balenghien et. al., 
2014).  Taken  in  their  entirety,  these  studies  convincingly  implicated  a  range  of  widespread  and 
abundant farm-associated Culicoides species in the transmission of SBV, including at least the species 
Culicoides obsoletus, Culicoides scoticus and Culicoides chiopterus. 
About 1,250 Culicoides species are described worldwide and about 120 in Europe. Among these 
species, the most abundant species in non-Mediterranean Europe are C. obsoletus and C. scoticus, 
usually  grouped  into  the  Obsoletus  complex.  This  complex  dominates  Culicoides  collections  in 
European farms, becoming less abundant or absent in high Scandinavian latitudes, in Mediterranean 
regions and at high altitudes. The Obsoletus complex is often associated with Culicoides dewulfi and 
C. chiopterus which are known to be abundant along the English Channel and the North Sea in France, 
England, and Netherlands, whereas these species become rare or absent in southern Europe. Finally 
Culicoides impunctatus and Culicoides newsteadi are very abundant species respectively in northern 
Europe, as in Scotland, and in the Mediterranean region. Schmallenberg virus: State of Art 
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The transmission of a virus by a biological vector is the process in which virus particles ingested with 
the blood meal infect the midgut cells, replicate, disseminate throughout the vector, infect the salivary 
glands  and  be  transmitted  via  saliva  during  subsequent  blood  feeding.  A  midgut  barrier  to  BTV 
infection has been described in C. sonorensis, which can limit the infection of midgut cells or the 
dissemination to target organs including salivary glands (Mellor et. al., 2009b). Although salivary 
barriers have been described for several viruses in different mosquito species, these have yet to be 
identified in any species of Culicoides, suggesting that females with a fully disseminated infection 
would be able to transmit (Mellor et. al., 2009b). Thus, the recovery of virus from saliva illustrates a 
transmissible  infection;  the  recovery  in  head,  legs  or  wings  illustrates  a  disseminated  infection, 
whereas the recovery in a pool of entire insects may indicate an infection limited to the midgut cells. 
Detection  of  viral  DNA  by  rt-PCR  assay  prove  the  presence  of  viral  genome  segments,  but  not 
necessary the presence of infectious viral particles. Nevertheless, a comparison of Ct values obtained 
by a semi-quantitative rt-PCR assay and results of isolation of infectious BTV suggested that Ct values 
may  be  used  to  define  if  infection  could  be  considered  as transmissible  (fully  disseminated  with 
infectious virus) or subtransmissible (not fully disseminated or without infectious virus) (Veronesi et. 
al., 2013a). This approach may be applied to SBV infections (Veronesi et. al., 2013b). 
Intrathoracic inoculation of Culex pipiens and Aedes albopictus mosquitoes strongly suggested that 
SBV can replicate in individuals when introduced directly into the haemocoel, bypassing mid-gut 
barriers to arbovirus dissemination (Balenghien et. al., 2014). Oral infection, however, did not result in 
Ct values indicative of full SBV dissemination in either mosquito species (Balenghien et. al., 2014). 
Experimental  studies  on  vector  competence  were  also  conducted  in  the  Netherlands  using  An. 
atroparvus mosquitoes. The mosquitoes were blood-fed on SBV-infected animals and incubated at 
25 °C. For up to five days post-infection SBV S-segment RNA was detectable via PCR from the heads 
of the insects but not the abdomens. This result therefore probably represents residual contamination 
after feeding rather than a disseminated infection (EC, 2014). While these results should be interpreted 
with caution as they utilised inbred colony lines, this study provides preliminary evidence that these 
mosquitoes may not play a substantial role in transmission of SBV in the field. Systematic studies to 
characterise biting rates of mosquito species on livestock in Europe, however, would be useful in 
understanding the role of this group to potentially transmit pathogens such as SBV. 
Vector  competence  studies  in  Culicoides  nubeculosus  colony  lines  highlighted  the  ability  of 
Culicoides to replicate SBV to transmission level after intrathoracic inoculation and oral exposure 
(Veronesi  et.  al.,  2013b;  Balenghien  et.  al.,  2014).  These  studies  have  indicated  low  rates  of 
competence of approximately 3 % for C. nubeculosus (Veronesi et. al., 2013b; Balenghien et. al., 
2014), similar to rates assessed for BTV with this colony line (Veronesi et. al., 2013a). It is important 
to note, however, that such infection rates have been demonstrated to vary with vector population for 
BTV-9  (0.4  to  7.4 %  for  Obsoletus  complex  from  different  geographic  regions  of  the  United 
Kingdom)  or  other  Culicoides-borne  arboviruses  (Tabachnick  1996;  Carpenter  et.  al.,  2006). 
Culicoides nubeculosus remains rare in light trap collections carried out across Europe suggesting a 
limited potential role in SBV transmission, but the abundance of this diurnal species may be under-
estimated by light traps. Preliminary evidence was also provided that C. scoticus is able to replicate 
SBV to transmissible levels (Balenghien et. al., 2014), albeit using a technique (pledglet feeding with 
sugar) that is likely to result in virus being transported to the crop rather than the gut (Jennings et. al., 
1988). 
A detailed study of SBV replication and dissemination in the model species Culicoides sonorensis 
allowed determination of RNA levels in studies carried out on field collected midges that were likely 
to represent transmissible infections (Veronesi et. al., 2013b). Studies in Belgium, Netherlands and 
France (De Regge et. al., 2012; Elbers et. al., 2013a; Balenghien et. al., 2014) confirmed the role of C. 
obsoletus, C. scoticus and C. chiopterus as highly probable vectors of SBV in northern Europe, and 
especially C. obsoletus, which is among the most abundant livestock-associated species in the region 
(Meiswinkel et. al., 2008; Carpenter et. al., 2009; Venail et. al., 2012) and its apparently ubiquitous 
distribution on farms across the Palaearctic and Nearctic may facilitate spread of SBV to new regions 
(Table 4.1). On the contrary, C. dewulfi, C. pulicaris, C. nubeculosus and Culicoides punctatus were Schmallenberg virus: State of Art 
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implicated as suspected vectors in Belgium, France or Poland (De Regge et. al., 2012; Larska et. al., 
2013; Balenghien et. al., 2014), although quantities of SBV RNA detected were equivocal in defining 
the level of dissemination that had occurred (Veronesi et. al., 2013b). 
Studies of C. imicola in Sardinia (Table 4.1) failed to convincingly implicate this species in SBV 
transmission through detection of SBV RNA (Balenghien et. al., 2014), despite its well documented 
role in transmission of other Culicoides-borne arboviruses (Mellor et. al., 2009b) and association with 
BTV outbreaks in Italy  (Goffredo  et. al., 2003; Goffredo  et. al., 2004). The fact that  C. imicola 
dominated the Culicoides fauna in Sardinia and especially at outbreak sites where only very limited 
numbers  of  the  Obsoletus  complex  were  present,  however,  indicates  its  probable  involvement  in 
transmission of SBV in Sardinia in 2012 (Balenghien et. al., 2014). An absence of pools of C. imicola 
containing significant quantities of SBV RNA may have been due to the time of sampling, thus further 
screening within the distribution this species would be desirable to identify species involved in SBV 
transmission in Mediterranean region. The vector competence studies carried out currently in Italy 
would allow the assessment of the experimental competence of C. imicola against SBV. 
The detection of RNA in field collected nulliparous females in Poland (Larska et. al., 2013) was not 
sufficient to challenge the current statement of the absence of vertical transmission in virus/Culicoides 
model (Mellor et. al., 2000), because the presence of viral RNA does not necessarily indicate the 
presence  of  infectious  virus  at  a  transmissible  level  (Veronesi  et.  al.,  2013a).  Often  vertical 
transmission rates are low (about 4 % for Aedes/dengue virus, and about 0.8 % for Culex/West Nile 
virus) and therefore statistically difficult to detect. It might be especially difficult to determine for 
European  Culicoides  as  probable  vector  species  have  not  been  colonized  and  field  collected 
individuals are difficult to feed on blood. 
From 2011 to 2013, SBV has spread across a huge geographic area in Europe at a rate substantially 
exceeding that of the BTV-8 epidemic which occurred in the same region from 2006 to 2010 (Elbers 
et. al., 2012; Meroc et. al., 2013a,b). A partial explanation for this phenomenon could be the absence 
of animal movement restrictions, but this will be discussed in section 7. Additionally, however, it was 
hypothesised that the vector competence of Culicoides for SBV may exceed rates recorded for BTV 
either in the number of species capable of transmitting the virus or in the proportion of individuals 
within a species able to act as vectors. This hypothesis receives support from the fact that the related 
Akabane virus is isolated at a far higher frequency than BTV from Culicoides in Australia (St George 
et. al., 1978), although comparative laboratory-based investigations of susceptibility rates in vector 
species have not been performed. The review of studies conducted to date found equivocal support for 
this hypothesis. Indeed, observed SBV infection rates (Table 4.1) were usually greater than those 
previously recorded during BTV-8 epidemic, but the proportion of Culicoides exposed to viraemic 
hosts within screened populations is unknown and in general the numbers of individuals and sites 
investigated in initial studies were low (De Regge et. al., 2012; Rasmussen et. al., 2012; Elbers et. al., 
2013a).  
The most straightforward way to assess the true competence of populations is to carry out infection 
studies of field-collected Culicoides in the laboratory using either viraemic hosts or artificial means of 
feeding, as conducted for BTV (Jennings et. al., 1988; Carpenter et. al., 2006; Carpenter et. al., 2008). 
As  the  timing  of  animal-based  experiments  in  biosecure  containment  with  population  peaks  in 
Culicoides is logistically  challenging,  pledgelet-based  blood feeding  methods are  most  commonly 
employed to assess infection rates. Membrane-based methods, such as those employed to feed colony 
Culicoides and mosquitoes in this study currently result in extremely poor rates of feeding in field 
collected Culicoides from northern Europe (Jennings et. al., 1988; Venter et. al., 2005). As it is known 
that  pledgelet  feeding  significantly  underestimates  the  proportion  of  competent  Culicoides  in  a 
population (Venter et. al., 2005) it is therefore vital that standard membrane-based techniques are 
developed for northern European species. Then, vector competence studies could be systematized with 
standardised protocols to test different field collected Culicoides populations against SBV. Schmallenberg virus: State of Art 
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Table 4.1: Published reports of Schmallenberg virus detection from field collected Culicoides in Belgium, Denmark, Netherlands, Italy, Poland and France 
using quantitative detection assays. 
Country  Period  Pool constitution
a  Species  No. midges (pools) 
tested 
No.  positive 
pools 
Mean  Ct  value 
[min-max] 
Minimum 
infection rate 
Reference 
Belgium  August to October 2011  25  heads (PF)   Obsoletus complex  688 (34)  5  33.9 [30.7-36.0]  0.73%  De Regge, 2012  
      C. obsoletus  283 (32)  3  35.9 [34.9-36.5]  1.06%   
      C. scoticus  240 (27)  0       
      C. dewulfi  181 (20)  2  35.2 [32.2-38.1]  1.10%   
      C. chiopterus  227 (23)  1  28.7  0.44%   
      C. pulicaris  89 (11)  1  37.9  1.12%   
Denmark  October 2011  5 entire females  Obsoletus group  91  2  26.0 [25.0-27.6]  2.20%  Rasmussen, 2012 
Netherlands  August to September 2011  10 heads (NF or PF)  Obsoletus complex  2,300 (230)  12  24.6 [19.6-36.0]  0.52%  Elbers, 2013 
      C. obsoletus    1  24.6     
      C. scoticus    10  25.0 [19.6-36.0]     
      C. dewulfi  1,300 (130)  0       
      C. chiopterus  1,440 (144)  2  31.6 [27.9-35.4]  0.14%   
      C. punctatus  1,050 (105)  0       
  May to September 2012  50 entire females (PF or 
GF) 
Obsoletus complex  2,100 (42)  2  36.3 [35.0-37.7]  0.10%  Elbers, 2013 
    C. dewulfi  1,300 (26)  0       
      C. chiopterus  1,050 (21)  0       
      C. punctatus  1,550 (31)  0       
      C. pulicaris  500 (10)  0       
Italy  September to November 2011  < 50 entire females  Obsoletus complex  1,104  5  29.0 [26.0-33.0]  0.45%  Goffredo, 2013 
  May 2012    Obsoletus complex  769  1  27.0  0.13%   
Italy
b  October to December 2012  < 50 entire females (PF)  C. imicola  22,126 (456)  2  36.0 [34.0-38.0]  0.04%  Balenghien, 2014 
      C. newsteadi  5,503 (124)         
      Obsoletus complex
d  131         
      C. pulicaris  72 (13)         
Poland  September/October 2011 and 
April to October 2012 
~ 20 entire females (NP, 
PF or GF)
c 
Obsoletus complex  ~ 3,600 (181)  28  ~ 29.8 [17.5-39.4]  0.78%  Larska, 2013 
  C. punctatus  ~ 2,100 (108)  6  ~ 31.4 [23.9-37.2]  0.29%   
France
b  October 2011  5 entire females  Obsoletus complex
d  1 734  10  32.9 [23.4-38.2]  0.58%  Balenghien, 2014 
      C. obsoletus    8  34.4 [28.3-38.2]     
    < 50 entire females  C. dewulfi  1 729 (47)  0       
      C. chiopterus  1 224 (40)  2  32.0 [30.6-33.4]  0.16%   
      C. pulicaris  271 (27)  1  38.3  0.37%   
      C. newsteadi  65 (12)  0       
      C. nubeculosus  43 (7)  1  28.8  2.33%   
      C. lupicaris  24 (9)  0       
(a):   PF: parous females; NF: nulliparous females; GF: gravid females 
(b):   We did not report here results for species for which less than 20 individuals were tested 
(c):  The number of Culicoides per pools was not given precisely, it ranged from 9 to 60 (meanly 20). Blood-fed females were also tested in this study, but we did not report the results here 
(d):   Individuals of the Obsoletus Complex were tested individually or by pools and then positive individually Schmallenberg virus: State of Art 
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4.2.  Semen 
Different authors reported variable excretion patterns in SBV-infected bulls (Table 4.2). Coincidental 
detection  of  SBV-RNA  in  semen  together  with  early  SBV  antibodies  in  the  blood  was  reported 
(Hoffmann et. al., 2013), although viraemia is very short. From initial field data, SBV-RNA was 
detected in only 55 semen batches out of 1719 samples tested in seropositive bulls (3 %; ProMed-mail: 
Schmallenberg virus – Europe, 2012, 76 and 77). When semen samples were strictly selected around 
seroconversion from period targeted or experimental bulls (Hoffmann et. al., 2013; Ponsart et. al., 
2014; Steinrigl et. al., 2013; Van der Poel et. al., 2013), the proportion of positive batches averaged 
6 % (72/1118), which has to be considered as an overestimated frequency rate compared to the total 
number of straws produced in Europe, due to the selection bias. Following experimental infection, the 
highest SBV RNA concentrations in semen were observed between 4–7 days post infection, but SBV-
RNA detection in semen can be independent from SBV viraemia. In this case, viable SBV was only 
isolated from blood samples and not from semen or genital tissues (Van der Poel et. al., 2013).  
Extraction methods influenced sensitivity of detection (Hoffmann et. al., 2013), but trizol has been 
validated for the efficient extraction of RNA from matrices with a potentially high amount of PCR 
inhibitors (Vanbinst et. al., 2010; Hoffmann et. al., 2013). As shown in Table 4.2, a large variability 
has been reported in the excretion of SBV in semen of naturally infected bulls. Positive results were 
observed in  different breeds  (Ponsart  et.  al., 2014).  Particular patterns  in  semen  viral  RNA  were 
characterized as i) sustained and prolonged SBV genome in consecutive semen batches, up to 2.5 
months following seroconversion in rare cases (Hoffmann et. al., 2013; Ponsart et. al., 2014), or ii) 
single  positive  semen  batch  (Hoffmann  et.  al.,  2013;  Steinrigl  et.  al.,  2013)  or  iii)  intermittent 
excretion patterns (Hoffmann et. al., 2013; Van der Poel et. al., 2014) or iv)  absence of SBV-RNA in 
semen (Hoffmann et. al., 2013; Ponsart et. al., 2014). Recent papers demonstrated from few targeted 
semen batches that SBV RNA-positive bovine semen could contain infectious SBV using the most 
sensitive experimental transmission model such as subcutaneous injection of positive semen batches in 
calves  (Schulz  et.  al.,  2014)  or  in  IFNAR  -/-  mice  (Ponsart  et.  al.,  2014;  Schulz  et.  al.,  2014). 
However, there is no scientific evidence of transmission through insemination and the risk may be 
considered as low compared to the principal route of transmission via Culicoides. No positive semen 
batch has been observed in sheep and goats (Table 4.2). 
According to Hoffmann et. al., 2013, the rare prolonged SBV-RNA excretion in bovine semen could 
be explained by the infection of seminal cells, gonadal or testicular tissues or any other tissue in some 
of these bulls, as it has also been described for bovine herpes virus type 1  (van Oirschot, 1995). This 
was supported by the results of the SBV-RNA distribution in seminal fractions indicating that SBV-
RNA can be detected in seminal cells of semen collected from bulls that showed consecutive positive 
RTqPCR results together with seroconversion, but not in semen of bulls with only a single SBV 
positive semen batch (Hoffmann et. al., 2013).  
It remains difficult to compare behaviour between SBV and other worldwide Orthobunyaviruses such 
as Akabane, Aino or Cache Valley viruses in semen, considering the facts that i) limited scientific data 
are available regarding semen shedding, ii) a low proportion of SBV-seropositive bulls with positive 
RT-PCR results in semen, iii) the virus detection methods developed for semen need to be highly 
sensitive to detect RNA viruses (specific extraction protocols have been developed recently for SBV 
and were unavailable when similar tests were developed for other viruses of the same group). 
Controversial data were published for Akabane virus, as no virus was detected using culture in semen 
collected from viraemic bulls following experimental infection (Parsonson et. al., 1981a; Table 4.2). 
Gard et. al., (1989) used bull semen naturally infected by viruses of the Simbu serogroup to inoculate 
sheep. Although four animals showed seroconversion, the possibility of natural infection by vectors 
could not be ruled out. Intrauterine inoculation of Akabane virus in cattle during artificial insemination 
did not lead to clinical signs, although most  of the animals developed a viraemia. The virus was 
isolated from a certain number of tissues, including the reproductive system (ovaries, uterus) and the 
lymph nodes of cows slaughtered up until 7 days after intrauterine inoculation (Parsonson  et. al., Schmallenberg virus: State of Art 
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1981b). All the pregnant cows gave birth to healthy calves (Parsonson et. al., 1981b). It is important to 
highlight that results here presented on Akabane were obtained during the decade of 1980s, and much 
have  been  developed  regarding  detection  methods  and  facilities,  which  might  help  to  elucidate 
differences in their findings. 
Limited  numbers  of  articles  have  studied  the  risks  of  transmission  of  SBV  virus  via  semen  and 
embryos. Recent data indicate that SBV may be detected from semen samples with a low frequency (< 
6  %).  However,  there  is  no  scientific  evidence  of  transmission  through  insemination.  This  is  in 
agreement with epidemiological data, indicating that the vector transmission remains the principal 
route explaining the dissemination of such viruses (see Section 7). 
Table  4.2:  Impact  of  Orthobunyaviruses  of  the  Simbu  group  on  the  male  genital  tract 
(Akabane=AKAV,  Schmallenberg=SBV,  VNT=virus  neutralisation  test,  dpi=days  post  infection, 
dg=days of gestation, qRT PCR=quantitative reverse transcriptase polymerase chain reaction). 
  
Virus  Reproductive disorders  Country  Species  Reference 
AKAV 
Experimental  infection  of  8  bulls  and  2  controls; 
subcutaneous inoculation of 1-2 ml of semen in 10 Hereford 
cows; viraemia in the 8 bulls (2-9 dpi); no viruses isolated 
from the semen, no seroconversion of cows  
Australia  Cattle  Parsonson et. 
al., 1981a 
Epidemiological study over 5 years in 29 bulls. Virus isolated 
from blood and semen. Intravenous inoculation of 12 sheep 
(3 by bull) followed by serology.   
51  episodes  of  viraemia  related  to  14  viruses.  
Seroconversion of sheep inoculated  with blood (Aino: 2/2; 
Akabane: 6/8) or infected semen (Aino: 2/2; Akabane: 6/8). 
Natural infection of sheep not ruled out. 
Australia  Cattle  Gard et. al., 
1989 
SBV 
740  semen  batches  from  94  SBV-infected  and 
seroconverting/seroconverted bulls. 26 semen batches from 
11 bulls reacted positive in the RT-qPCR analyses with Cq-
values from 26 to 37.  
   
ProMed-mail: 
SBV virus - 
Europe (76) 
-Central  Veterinary  Institute,  The  Netherlands:  55  semen 
samples  tested  from  8  seroconverting  bulls;  3  positive 
samples using qRT PCR, from 2 different bulls. 
-ANSES  and  LNCR,  France:  904  semen  samples  by  160 
seropositive  bulls;  26  positive  samples  using  qRT  PCR, 
from 2 different bulls. 
   
ProMed-mail: 
SBV virus - 
Europe (77) 
-12  extraction  methods  comparatively  validated  using  a 
dilution  series  of  SBV-spiked  semen.  Most  sensitive 
extraction (Trizol® LS Reagent with combined purification 
of  the  viral  RNA  with  magnetic  beads)  and  RT-PCR 
subsequently  used  with  766  semen  batches  from  95  field 
SBV-infected  bulls  (collected  between  May  and  October 
2012) to detect SBV-RNA. 29 of 766 semen batches from 11 
of 95 SBV-infected bulls positive (Ct 26 to 37). Intermittent 
virus excretion observed in 2 bulls.  
- no SBV found in 390 straws batches collected from May to 
December 2011 from 38 bulls that were SBV seropositive 
Germany  Cattle  Hoffmann et. 
al., 2013 
2 bulls inoculated subcutaneously with viraemic calf serum. 
Semen  collected  daily  from  both  animals  for  21  days  and 
tested for SBV by qRT–PCR. Bulls necropsied 24 dpi. SBV 
RNA  detected  in  semen  from  both  bulls  (trizol  based 
extraction protocol). The highest SBV RNA concentrations in 
semen between 4–7 dpi, but low concentrations (Ct  values 
30–39). Viable SBV only isolated from blood samples and 
not from semen or genital tissues. 
Nether-
lands  cattle  Van der Poel 
et. al.,., 2013 Schmallenberg virus: State of Art 
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Extraction  (Trizol®  LS  Reagent/Chloroform  treatment 
followed  by  silica  membrane  based  purification)  and  RT-
qPCR in 164 semen batches from 7 bulls. Positive results in 7 
of 164 semen batches from 7 SBV-infected bulls (one single 
positive batch / bull) 
Austria  Cattle  Steinrigl et. 
al., 2013 
6 semen batches from 6 bulls (Cq values: 26.4-36.4) injected 
subcutaneously to 6 to 9-month-old heifers. 2 SBV infections 
were confirmed. 
Confirmation of infectivity from 1 single straw injection (one 
confirmed infectious batch) with 5 additional cattle. 3 SBV 
infections were confirmed. 
20  SBV  RNA  positive  semen  batches  from  11  bulls 
subcutaneously injected into 40 IFNAR  -/- mice (4-6 weeks 
old).  Only negative results reported. 
Germany  Cattle  Schulz et. al., 
2014 
7 bulls, 1 to 5 years of age, seroconverted between Sept 2011 
and Dec 2012, with semen production including at least 14 
ejaculates, collected from 4 weeks before to 4 weeks after the 
first  seropositive  sample.  Extraction  (Trizol®  LS  Reagent 
with combined purification of the viral RNA with magnetic 
beads Trizol based extraction) and qRT-PCR with 146 semen 
batches from 7 SBV-infected bulls: 29 positive batches from 
3 bulls.   
Semen replicates (each 100 µl) from 1 bull (4 SBV-infected 
ejaculates) injected subcutaneously into the neck scruff of 3 
or 4 adult IFNAR-/- mice. Viraemia and presence of SBV-
specific antibodies detected in mice inoculated with highly 
positive semen batches (Ct values <23).  
France  Cattle 
Ponsart et. al., 
2014 
(accepted) 
2 bocks inoculated subcutaneously with a SBV isolate (1 ml 
Vero cell culture 106 TCID50). Semen collected from both 
animals 1 or 2 times a week (7, 9, 14, 16, 21, 25, 28 dpi) and 
tested for SBV by qRT–PCR. Bocks necropsied 28 dpi. No 
SBV RNA detected in semen from both animals. 
France  Goat  LNCR, 
unpubl. data 
       
4.3.  Vertical Transmission 
Vertical transmission is the passage of an infection from a mother to her embryo or foetus which 
persists to the point of birth. In the case of SBV, vertical transmission can be considered in both its 
insect vectors and its ruminant hosts.    
No viruses have been shown to be vertically transmitted by colony-reared Culicoides, although viral 
antigens have been detected in their reproductive structures (Mellor, Carpenter & White, 2009a). Two 
studies  provide  limited  evidence  for  vertical  transmission  of  viruses  by  Culicoides  under  field 
conditions. BTV RNA was detected in pools of larval Culicoides in the U.S.A. (White et. al., 2005), 
although attempts to isolate live virus were not successful. More recently, SBV RNA was detected in 
nulliparous Culicoides in Poland (Larska et. al., 2013). As described in Section 4.1, the significance of 
this  result  should remain in  doubt  until  live  virus  is  isolated  or  a  fully  disseminated  infection  is 
detected  in  Culicoides  known  to  have  not  taken  a  bloodmeal.  Hence,  the  evidence  for  vertical 
transmission of SBV by Culicoides remains very slight. 
Vertical transmission of SBV in ruminant hosts would require the offspring of infected mothers to be 
infected with live virus when born. This could apply to clinically-affected offspring, if they live for a 
period of time after parturition, or clinically healthy offspring. In both cases, for vertical transmission 
to be epidemiologically important it must be feasible for the virus to be transmitted from the offspring 
to other ruminants or Culicoides. 
Studies have detected SBV RNA in clinically-affected live new-born animals several days after birth. 
In Belgium, a 7-day old calf with signs of Schmallenberg was euthanized and SBV genomes were 
detected  in  CNS  samples  but  not  in  a  variety  of  other  tissues  (Garigliany  et.  al.,  2012).  In  the 
Netherlands, a 10-day old clinically-affected calf was euthanized and evidence for SBV was detected Schmallenberg virus: State of Art 
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in brain tissue by PCR and in brain and spinal cord tissue by immunohistochemistry (Peperkamp et. 
al., 2012). 
These results suggest that vertical transmission of SBV can occur in cattle, although it should be noted 
that isolation of live SBV from the blood or skin of newborn animals has not yet been reported, which 
would be a prerequisite for transmission to vectors. Live SBV in the CNS of newborns is unlikely to 
be transmitted further, indicating that this is likely to be an epidemiological dead-end. SBV has not 
been reported in healthy newborns of affected mothers. 
Pseudo-vertical transmission is the passage of infection from a mother to offspring shortly after birth 
(Phillips et. al., 2003). It may occur, for example, by the consumption of milk, or from exposure of the 
offspring to infectious birth tissues such as placenta. SBV has not been reported in milk and, although 
SBV has been detected in the external placenta and umbilical cord (Bilk et. al., 2012), it is considered 
unlikely that offspring would become infected with SBV after licking or ingesting these tissues as 
evidence suggests the virus cannot be transmitted by the oral route (Wernike et. al., 2013a). 
In conclusion, there is currently little or no evidence that vertical or pseudo-vertical transmission play 
an important role in the epidemiology of SBV. 
4.4.  Mechanism of Overwintering 
As discussed elsewhere in this report (section 4.1, 7.3.1) the evidence suggests that SBV is primarily 
transmitted  via  the  bites  of  infected  Culicoides.  The  duration  of  viraemia  is  not  clear;  although 
experimental infections suggest duration of only a few days, some field studies have indicated that 
SBV nucleic acid is present in blood samples for a period in excess of two weeks (Claine et. al., 
2013). However, the period of several months between confirmed transmission events is substantially 
longer than the period for which individual vertebrate hosts are likely to remain infectious, or the 
period for which adult  Culicoides are commonly believed to survive. This ability of the virus to 
“overwinter” – that is, to survive for prolonged periods during lower vector activity and no new hosts 
appear to be infected, is a characteristic previously observed in other Culicoides-borne viruses such as 
Akabane virus, bluetongue virus and African horse sickness virus. 
When contact between the primary vector population and the primary host population is interrupted, 
there  are  three  ways  that  a  virus  can  theoretically  persist:  in  the  vector  population,  in  the  host 
population,  or  via  an  alternative  transmission  cycle  involving  one  or  more  novel  vector  or  host 
populations. Persistence in the vector or host populations may be achieved via horizontal (direct) 
transmission  between  individuals,  vertical  transmission  from  infected  parent  to  offspring,  or 
persistence in individuals. Because insect vectors are generally infectious for life but relatively short-
lived, persistence in individual vectors would require the survival of infected vectors for substantially 
longer periods than are currently believed to occur in the field (Wilson et. al., 2008). 
In the case of SBV, persistence via long-lived adult Culicoides has previously been considered for 
other Culicoides-borne viruses and is highly unlikely to be able to account for overwintering periods 
of longer than three months. However, there are several well-documented reports of SBV infections 
during the winter (e.g. Davies and Daly 2013; Shaw et. al., 2013; Wernike et. al., 2013a,b). During 
this  period,  adult  Culicoides  would  normally  be  expected  to  be  absent  or  inactive,  although 
entomological surveillance during one of these studies (Wernike et. al., 2013a) confirmed Culicoides 
activity at a very low level despite maximum temperatures of only 9 °C. However, arboviruses require 
a  minimum  threshold  environmental  temperature  to  replicate  to  transmissible  levels  in  the  insect 
vector, and although this has not yet been measured directly for SBV it is likely to be between 10 and 
14 degrees (see Section 7.1 and Table 7.1). Consequently, these observations could only be explained 
either  as  transmission  from  extremely  long-lived  Culicoides  that  had  completed  the  extrinsic 
incubation period during warmer conditions, or via another as-yet-unknown transmission route. 
The potential for persistence within the Culicoides population via vertical transmission is also likely to 
be low; as discussed in section 4.3 above, SBV RNA (like BTV RNA) is believed to be occasionally 
transmitted  to  offspring,  but  intact  virus  has  not  been  detected.  Horizontal  transmission  of  virus Schmallenberg virus: State of Art 
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between individual Culicoides has never been shown and furthermore could not by itself explain the 
overwintering of SBV during periods of adult vector absence.  
Persistence in the population of known ruminant hosts is also possible but appears to be rare. The only 
evidence for persistent infections with SBV is the shedding of infectious virus in the semen of affected 
bulls  for  a  prolonged  period  (section  4.3),  but  this  is  very  rare.  Transplacental  transmission  to 
offspring occurs, but live virus has not been demonstrated to be present in blood. Evidence suggests 
the virus cannot be transmitted by the oral route (Wernike et. al., 2013a).  
Regarding the potential for SBV to overwinter via continued transmission in as-yet unrecognised 
reservoir host species, the evidence for SBV‟s ability to infect other host species is discussed in 
section 2 of this report and the specific studies are detailed in Appendix 2. To summarise, there is no 
strong evidence that any other species plays a substantial role in the epidemiology of SBV, but the 
limited data available mean that the potential for any of these species, or of another as-yet unidentified 
species, to act as an SBV reservoir during apparently transmission-free periods cannot be ruled out. 
In conclusion, while SBV is able to overwinter, the exact mechanism remains unknown. While the 
epidemiological data indicate that SBV is capable of surviving in the absence of competent vector 
activity for prolonged periods, the data available suggest that this is unlikely to occur via the vector 
population.  There  is  also  no  strong  support  for  the  hypothesis  that  additional  host  reservoirs  are 
involved in the persistence of infection, although this cannot be ruled out from the data available. The 
evidence does indicate that SBV can be transmitted transplacentally and that a limited number of 
infected bulls may shed infectious virus in semen for prolonged periods, but neither route has yet been 
shown to result in further transmission.  
5.  Duration of Immunity 
There are limited data on the duration of immunity following SBV infection. To date information is 
available on the duration of immunity in cattle in both experimental and field settings. However, no 
information has been published on the duration of immunity in sheep.  
In an experimental study of the duration of immunity in cattle, two heifers which had been infected 
previously,  and  which  were  seropositive,  could  not  be  reinfected  when  SBV  was  injected 
subcutaneously  eight  weeks  after  the  previous  infection  and  no  SBV  replication  was  detected 
(Wernike et. al., 2013a). This suggests that the duration of immunity in cattle is at least 56 days.  
The results of surveillance in Belgium, where serological surveys were carried out in the winters of 
2011/2012 and 2012/2013 (Méroc  et. al., 2013a,b,c), also provide information on the duration of 
immunity in cattle. In particular, the seroprevalence in animals of age between 12 and 24 months 
sampled in the 2011/2012 survey (87 %, 95 % CI: 84-89) was not significantly (P>0.05) different than 
that in animals older than 24 months of age sampled in the 2012/2013 survey (85 %, 95 % CI: 82-
88 %). This may indicate that the level of antibodies to SBV remains high for at least one year (Méroc 
et. al., 2013c). However, it should be noted that the same animals were not sampled in both surveys, 
though  the  sampling  scheme  was  similar  and,  hence,  results  should  be  comparable  between  the 
surveys. It should also be noted that there is not evidence either to refute long term immunity. 
6.  Seroprevalence Studies 
Epidemiological  studies  to  investigate  disease prevalence rely  on  selecting  representative  samples 
from the population of interest. In order to ensure precise and unbiased estimates of the population, 
sufficient samples must be collected to warrant sufficient statistical power (EFSA, 2013b). It is crucial 
to set the specific objective of the study, to follow the appropriate statistical procedure together with 
the right use of the methodology (i.e. study design, parameter of the population to be estimated and 
tested,  etc.).  Sampling  methods  vary  depending  on  the  rationale  of  the  study  and  the  resources 
available. In a systematic sampling approach subjects from the population frame are selected at regular 
intervals, once the first case has been randomly chosen. If instead a random sampling method is used Schmallenberg virus: State of Art 
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each element of the population frame has the same probability of being chosen. A stratified sampling 
design involves the identification of different strata with similar characteristics, and in each of the 
strata a random sample can be chosen to represent each subpopulation. In the case of cluster sampling 
design groups of elements of the population frame are selected rather than individual elements, such 
groups  are  known  as  clusters.  In  addition to  selecting  an  appropriate  sampling  method,  sampling 
frames  must  be  identified.  Sampling  frames  are  made  of  different  strata  or  clusters  that  form  a 
population.  In  veterinary  medicine  commonly  used  strata/clusters  are  species,  herds/flocks  and 
individual animals. 
The validity of a study on disease seroprevalence depends on sample size (sample size calculations 
should be documented a priori, aiming to achieve specific confidence level with a pre specified power 
to test the hypothesis of interest), sampling design, sampling frame and the accuracy of the test used.  
Several seroprevalence studies have been conducted and published since the emergence of SBV in 
Europe. Twelve studies were identified for domestic ruminants from eight countries (Appendix A). 
Their seroprevalence values and confidence intervals were grouped by sampling unit (i.e. animal and 
herd) and geographical context of the samples taken (i.e. national and regional) and were plotted in 
Figure 6.1 and Figure 6.2. 
 Schmallenberg virus: State of Art
 
EFSA Journal 2014;12(5):3681  21
 
 
Figure 6.1:  Seroprevalence (in percentage, black dots) and 95
th Confidence Intervals (bars) for SBV in domestic ruminants (cattle in red, goats in blue and 
sheep in yellow) grouped by sampling unit and geographical coverage (Regional). Solid lines represent intervals provided by cited authors, dotted lines show 
exact intervals calculated from data provided in cited papers.  
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Figure 6.2:  Seroprevalence (in percentage, black dots) and 95
th Confidence Intervals (bars) for SBV in domestic ruminants (cattle in red, goats in blue and 
sheep in yellow) grouped by sampling unit and geographical coverage (National). Solid lines represent intervals provided by cited authors, dotted lines show 
exact intervals calculated from data provided in cited papers. 
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Seroprevalence  values  and  their  confidence  intervals  are  highly  variable  among  studies  and 
comparison of the results obtained are very limited due to the difference between methods used to 
collect (referring to sampling frame, population frame, sampling design used, sampling unit) and data 
analysis performed. It is likely that the power achieved by some studies might not be sufficient to 
support inferences at population level and this could compromise the reliability of the estimation and 
their interpretations, given samples size and sampling design used in some of the studies. It should be 
highlighted that for seroprevalence studies conducted at national level, larger variation is observed for 
animal level seroprevalence estimations compared to the herd level estimations. In five of the National 
level studies in cattle between herd seroprevalence were estimated above 90 %. 
7.  Geographical and Temporal Spread of SBV 
The spread of SBV has been explored at a range of scales, from within individual holdings to 
the spread across Europe (Gubbins et. al., 2014a,b). Here we provided summaries of the approaches 
used and results of these two articles. 
7.1.  SBV Within Herd Specific Transmission Parameters 
7.1.1.  Background and approach 
Several  early  studies  of  SBV  transmission  within  a  herd  used  models  parameterised  by  data  on 
Akabane virus (a related Culicoides-borne virus) and Bluetongue virus (BTV) (an unrelated, but well-
studied Culicoides-borne virus) when exploring scenarios for the spread of SBV (European Food 
Safety Authority 2012a,b; Bessell et. al., 2013). However, suitable data, notably from seroprevalence 
surveys (Elbers et. al., 2012; Gache et. al., 2013; Méroc et. al., 2013a,b; Veldhuis et. al., 2013), have 
become available that allow inferences about the transmission of SBV to be drawn directly. 
To  draw  such  inferences  a  stochastic  compartmental  model,  whose  structure  is  similar  to  one 
previously developed for BTV (Gubbins et. al., 2008; Szmaragd et. al., 2009), was developed and 
fitted to data on the seroprevalence of SBV in cattle and sheep farms in Belgium (Méroc  et. al., 
2013a,b) and the Netherlands (Veldhuis et. al., 2013). Parameters in the model were estimated using 
approximate Bayesian computation rejection sampling (Marjoram et. al., 2003; Toni et. al., 2009). 
This  approach  generates  distributions  of  parameters  for  which  the  within-farm  seroprevalences 
predicted by the model are consistent with those observed in the field. Prior distributions for model 
parameters (see Fig. 7.1) were generated using data from the published literature. For some parameters 
data relating to SBV were available, but data for BTV were used instead where this was not the case 
(Gubbins et. al., 2014a). Schmallenberg virus: State of Art 
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Figure 7.1:  Marginal posterior distributions for epidemiological parameters for Schmallenberg virus 
(SBV): (a) probability of transmission from vector to host; (b) probability of transmission from host to 
vector; (c,d) mean duration of viraemia (days) in (c) cattle or (d) sheep; (e) virus replication rate; and 
(f) threshold temperature (°C) for virus replication. Each figure shows the prior (dotted black line) and 
posterior (solid black line) densities when the model for the within-farm transmission of SBV was 
fitted to seroprevalence data for cattle and sheep from Belgium and the Netherlands. 
7.1.2.  Results 
Transmission from vector to host was estimated to be very efficient (posterior median for probability 
of transmission from vector to host: 0.76) (Fig. 7.1a) and much more so than transmission from host to 
vector (posterior median for probability of transmission from host to vector: 0.14) (Fig. 7.1b). The 
mean  duration  of  viraemia  was  short  in  both  species,  but  was  estimated  to  be  shorter  in  cattle 
(approximately three days) than in sheep (approximately four days) (Table 7.1; Figs 7.1c,d). The virus 
replication rate (above the threshold temperature) was estimated to be approximately 0.03 per day-
degree (Table 7.1; Figs 7.1e). Finally, the threshold temperature for virus replication was estimated to 
12.3 °C (Table 7.1; Fig. 7.1f). 
   Schmallenberg virus: State of Art 
 
EFSA Journal 2014;12(5):3681  25 
Table 7.1: Posterior median and 95 % credible intervals (CI) for parameters in the model for the 
within-farm transmission of Schmallenberg virus (SBV). 
parameter  Median  95 % CI 
probability of transmission     
vector to host  0.76  (0.46, 0.95) 
host to vector  0.14  (0.07, 0.26) 
duration of viraemia (cattle)†     
mean (days)  3.04  (1.63, 5.91) 
scale parameter  11  (1, 20) 
duration of viraemia (sheep)†     
mean (days)  4.37  (2.24, 9.02) 
scale parameter  11  (1, 20) 
extrinsic incubation period†     
virus replication rate  0.030  (0.016, 0.045) 
threshold temperature  12.35  (10.52, 14.02) 
scale parameter  6  (2, 35) 
 
† the duration of viraemia in cattle and sheep and the extrinsic incubation period in vectors is assumed 
to follow a gamma distributions; the scale parameter relates the mean and variance of the distribution, 
such that variance is equal to the mean squared divided by the scale parameter 
The posterior densities (Fig. 7.1) were used to calculate the basic reproduction number (R0) for SBV in 
cattle and sheep and its dependence on temperature (Fig. 7.2). For both species, R0 increases with 
temperature up to 21 °C, after which it decreases. Moreover, the threshold at R0=1 is exceeded for 
temperatures between 13 °C and 34 °C. The basic reproduction number is slightly higher for sheep 
(Fig. 7.2b) compared with cattle (Fig. 7.2a), which is a consequence of the longer duration of viraemia 
in this species (Figs 7.1c,d). 
 
Figure 7.2:   Basic reproduction number (R0) for Schmallenberg virus in (a) cattle and (b) sheep and 
its dependence on temperature. Each figure shows the posterior median (circles) and 95 % credible 
intervals (error bars) for R0. The black dashed line indicates the threshold at R0=1. The grey diamonds 
indicate the median  R0 for Bluetongue virus computed from the uncertainty analysis presented in 
Gubbins et. al., (2012). 
7.1.3.  Discussion 
In several previous studies, BTV has been used as a proxy when studying SBV (European Food Safety 
Authority 2012a,b; Bessell et. al., 2013), yet our analysis of within-farm spread has highlighted three 
key differences between these two viruses. First, the duration of viraemia is much shorter in both cattle 
and sheep, typically around 3 to 4 days (Table 7.1; Figs 7.1c,d) compared with 16-20 days for BTV 
(see Gubbins et. al., 2008 and references therein). Despite this much shorter duration of viraemia (and, 
hence, infectiousness) the within-farm seroprevalence for SBV (Fig. 7.1; see Méroc et. al., 2013a,b; Schmallenberg virus: State of Art 
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Veldhuis  et.  al.,  2013)  is  still  typically  higher  than  what  was  observed  at  a  similar  point  in  the 
outbreak of BTV serotype 8 (BTV-8) in northern Europe in 2006/7 (Elbers et. al., 2008; Méroc et. al., 
2008;  van  Schaik  et.  al.,  2008).  This  observation  can  be  accounted  for  by  the  second  and  third 
differences between SBV and BTV: vector competence and virus replication.  
Vector competence was estimated to be 15 % (95 % credible interval (CI): 8-27 %) (Table 7.1), which 
is slight lower than that estimated for SBV in colony-reared C. sonorensis, a North American vector 
species (19 %; 95 % CI: 14-23 %) (Veronesi et. al., 2013b). This compares with estimates for vector 
competence for BTV in field-caught Culicoides populations of around 1 % (Carpenter et. al., 2006, 
2008). In the model, the posterior mean for the peak prevalence of SBV-infected midges was 0.48 % 
(95 % CI: 5×10
-4 to 2.64 %), which is consistent with reported prevalence in the field (De Regge et. 
al., 2012; Elbers et. al., 2013). 
In terms of virus replication, SBV is predicted by the model to have a lower threshold temperature for 
replication (12.3 °C) and to replicate at a faster rate above the threshold (0.03 per day-degree) (Table 
7.1)  than  has  been  reported  for  any  strain  of  BTV  (Carpenter  et.  al.,  2011).  However,  there  are 
currently only very limited data on SBV replication in Culicoides biting midges, which precludes 
comparison with our indirect inferences from the transmission model. 
Combining  the  posterior  estimates  for  the  individual  epidemiological  parameters  in  the  basic 
reproduction number, R0, shows that, despite the short duration of viraemia, the combination of higher 
vector competence and faster virus replication result in high values for R0 (peak R0 is approximately 
6.2 for cattle-only farms and 7.6 for sheep-only farms; Fig. 7.2) and exceeds the threshold at R0=1 for 
a wide range of temperatures (13-34 °C) (Fig. 7.2). This contrasts with estimates previously derived 
for BTV (Gubbins et. al., 2008; 2012) for which the median peak R0 is lower (3.8 in cattle and 3.4 in 
sheep) and for which the threshold of R0=1 is exceeded for a narrower range of temperatures (14-
31 °C) (Fig. 7.2). 
7.2.  SBV Regional Spread: A Network Approach 
7.2.1.  Approach 
To explore the transmission of SBV between farms, we adapted a stochastic model for the spread of 
BTV between farms in Suffolk and Norfolk, two counties in eastern England (Turner et. al., 2012). 
This is an area measuring approximately 100 x 100 km, containing over 3000 farms. Transmission 
between farms is assumed to occur by two mechanisms, animal movements and vector dispersal. 
Transmission via movements is simulated using recorded animal movements, while transmission via 
vector dispersal is described by a distance kernel. Rather than describe explicitly the dynamics of 
infection within a farm, a prevalence curve is constructed for an infected farm based on the time of 
infection, local temperature and seasonal vector activity. 
The between-farm model was adapted to examine the regional spread of SBV by replacing parameter 
estimates for BTV (Turner et. al., 2012) with those obtained for SBV (Table 7.1). The model also 
included a shorter latent period (2 days) for SBV (Hoffmann et. al., 2012) compared with BTV. To 
identify the roles played by differences in parameters between SBV and BTV, simulations were run 
for seven parameter sets (see summary in Table 7.2). These describe SBV, BTV, and BTV with the 
following modifications: estimated vector to host transmission rate for SBV (set 2); estimated host to 
vector transmission rate for SBV (set 3); estimated recovery rate in cattle and sheep for SBV (set 5); 
and estimated relationship between temperature and extrinsic incubation period (EIP) for SBV (set 6). 
In addition, we ran a simulation for BTV with the short, 2 day, incubation period for SBV (set 4). 
The effect of varying the day of introduction of virus (considering introduction in June, July, August 
and September) was explored. 
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Table 7.2: Impact of epidemiological parameters and movement restrictions on predicted regional 
spread (cumulative number of affected farms and extent of spread in km) of BTV and SBV. An 
affected farm is counted once only, even if it is infected, recovers and then reinfected. Infection is 
introduced on day 182, July 1
st. Results are for day 365 (31
st December). All results are the mean of 
100 simulations. 
parameter 
set  Description 
movement restrictions  Relative 
Reduction  no  yes 
no. 
farms 
radius  no. 
farms 
radius  no. 
farms 
radius 
BTV  all estimates for BTV  166  23.1  109  9.4  34.3  59.3 
set 2  as  BTV,  except  probability  of 
transmission from vector to host for 
SBV 
148  21.6  -  -     
set 3  as  BTV,  except  probability  of 
transmission from host to vector for 
SBV 
1191  34.8  -  -     
set 4  as BTV, except incubation period for 
SBV 
534  28.0  -  -     
set 5  as  BTV,  except  recovery  rates  in 
cattle and sheep for SBV 
12  8.1  -  -     
set 6  as BTV, except EIP parameters for 
SBV 
819  31.6  -  -     
SBV  all estimates for SBV  3281  50.9  3148  49.1  4.1  3.5 
 
7.2.2.  Results 
The mean cumulative number of cases and mean cumulative spread on day 365 are given in Table 7.2 
for each parameter set. For the two extreme cases (i.e. BTV and SBV), these measures are plotted 
against time (Fig. 7.3). A small reduction in the probability of transmission from vector to host (from 
0.9 [BTV] to 0.76 [SBV]) led to a negligible reduction in the cumulative number of cases and distance 
spread (Table 7.2; BTV vs. set 2). A large increase in the probability of transmission from host to 
vector (from 0.01 [BTV] to 0.14 [SBV]) led to a 7.2-fold increase in the cumulative number of cases 
and 1.5-fold increase in the distance spread (Table 7.2; BTV vs. set 3). The short incubation period of 
SBV  (2 days,  compared to  5-7  for  BTV)  more than  tripled  the  cumulative  number  of  cases  and 
increased the distance spread (Table 7.2; BTV vs. set 4). The short durations of SBV relative to BTV 
viraemia dramatically reduced the cumulative number of cases and distance spread (Table 7.2; BTV 
vs. set 5). The relationship between temperature and EIP for SBV led to a five-fold increase in the 
cumulative cases and 37 % increase in spread relative to BTV (Table 4; BTV vs. set 6). Therefore, 
most parameters for SBV increase the scale and size of outbreaks (compared to BTV), while one 
(short  viraemia)  decreases  them.  However, the net effect  of  including  all  of the  SBV parameters 
together is a 20-fold increase in the cumulative number of cases and doubling of the distance spread 
(without movement restrictions) (Table 7.2; BTV vs. SBV). 
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Figure  7.3:  Predicted  cumulative  (a)  number  of  cases  and  (b)  spread  versus  time  for  regional 
outbreaks  of  BTV  and  SBV.  Each  figure  shows  results  for  the  regional  spread  of  BTV  with  no 
movement restrictions (red line), SBV with no movement restrictions (blue line), BTV with standard 
movement  restrictions  imposed  during  an  outbreak  in  the  UK  (black  line)  and  SBV  with  a  total 
movement ban (green line). Each line is the mean of 100 simulations. Infection was introduced on day 
182 (i.e. 1 July). 
The effect of delaying the introduction of the infection after 1
st July reduces the size of the outbreak in 
terms of number of farms affected  by around 20 % with respect to introduction in August, while 
around 10 % reduction is observed in terms of mean distance (Figure 7.4). As the date of infection 
approaches 1
st September, the size of the outbreak drops dramatically, as there is little time for the 
infection to spread before cold temperatures reduce vector populations. The effect of introducing the 
infection earlier (i.e. 1
st June) is to achieve saturation (all farms infected) about a month earlier. 
    
Figure 7.4:   Effect of different dates of introduction of infection on predicted cumulative (a) number 
of cases and (b) spread versus time for regional outbreak of SBV. Each line is the mean of 100 
simulations. 
The  model  suggests that the  mean  cumulative  number  of  cases  for  SBV,  without any  movement 
restrictions, is over 30 times greater than the number predicted for BTV with standard BTV movement 
restrictions (Table 7.2 (3281 vs 109); and Fig. 7.3a). These are the conditions under which the two 
infections spread in the UK: standard movement restrictions were imposed in 2007 when BTV was 
detected in the UK, but no movement restrictions were imposed to try to control the spread of SBV. 
As targeted movement restrictions would not be possible for SBV without a widespread surveillance 
programme, we considered the effect of imposing a total movement ban. The model indicates that 
such a ban could reduce the mean cumulative number of cases of SBV by only about 4 % (Table 7.2 Schmallenberg virus: State of Art 
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and Fig. 7.3a) and the distance spread by only 3.5 % (Fig. 7.3b). By contrast, a BTV outbreak appears 
to be much more sensitive to the effects of movement restrictions. Imposing UK standard movement 
restrictions (i.e. less stringent than a total ban) achieves a 34 % reduction in cumulative cases and 
59 % reduction in the distance spread (Fig. 7.3). 
7.2.3.  Discussion 
Scaling the results for transmission within a farm (section 7.1) to the regional level indicated that the 
changes to the within-farm transmission parameters (latent period, duration of viraemia, competence 
and virus replication) are probably sufficient to account for the observed differences in spread between 
SBV and BTV. Three characteristics of SBV (compared to BTV) increased outbreak size and spread 
(namely, the greater host to vector transmission rate, the shorter latent period and modified virus 
replication rate with temperature), while one decreased them (shorter duration of viraemia). The net 
effect, however, is that SBV is predicted to infect many times more animals, and spread considerably 
further, than BTV in the same time period. 
Our model shows that imposing UK standard movement restrictions shows a considerable reduction of 
the size and spread of a BTV outbreak. It is difficult to apply such restrictions to SBV outbreaks, 
because the detection of infected farms would require extensive active surveillance and, therefore, a 
total movement ban might be a more straightforward approach. However, the model shows that even a 
total movement ban is expected to have only very minor effect on the final size and spread of an SBV 
outbreak. 
7.3.  SBV Continental Spread 
The continental-scale spread of SBV was described at NUTS (Nomenclature of Units for Territorial 
Statistics) level 2 (NUTS2). This was the level at which cases were reported to EFSA by each Member 
State. Countries included in the model were the 28 EU member states, Switzerland and Norway. 
Analyses were restricted to infections estimated to have occurred during 2011, so that we can assume 
a completely naïve population and, hence, do not need to take into account pre-existing immunity to 
SBV. 
7.3.1.  Spread between NUTS2 regions 
Transmission between regions was modelled using a kernel-based approach, similar to that adopted 
previously for SBV (European Food Safety Authority 2012b). However, three different shapes for the 
kernel  were  considered  (fat-tailed,  Gaussian  and  exponential),  as  well  as  density-dependent  and 
density-independent formulations (i.e. a total of six forms for the kernel were considered). Parameters 
were  estimated  in  a  Bayesian framework  and  the fits  of  the  models  using  different  kernels  were 
compared using the deviance information criterion (DIC) (Spiegelhalter et. al., 2002). 
The best fit was obtained using a density-dependent fat-tailed kernel (DIC=1175.2). The fit using this 
kernel was significantly better than for either the density-dependent Gaussian kernel (DIC=1260.5) or 
the  density-dependent  exponential  kernel  (DIC=1218.0).  Moreover,  the  density-dependent  kernels 
provided a significantly better fit than the density-independent kernels. This is consistent with the 
significant role of vectors in the spread of SBV, as spread by Culicoides dispersal is likely to be 
affected by herd/animal density. Alternative routes of transmission may, of course, still play a role, but 
those  which  result  in  density-independent  transmission,  such  as  via  the  movement  of  equipment, 
people, animals and animal products (including semen), are less likely to be the main mechanisms of 
spread. This conclusion is in accordance with the more detailed analysis of the spread of SBV between 
farms, which indicated vector dispersal is more important than animal movements (see section 7.2). 
7.3.2.  Spread within NUTS2 regions 
The number of cattle and sheep holdings within a region reporting arthrogryposis hydranencephaly 
syndrome  (AHS)  cases  in  cattle  or  sheep  were  described  by  a  Poisson  distribution  with  mean 
proportional to the species- and region-specific force of infection, the number of holdings keeping the Schmallenberg virus: State of Art 
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species in the region and seasonal vector activity. The force of infection was allowed to vary between 
regions. 
The model predicted that the force of infection was markedly higher (>10 times) for sheep than for 
cattle (Fig. 7.5a), and that there was considerable variation in the force of infection amongst regions. 
However, species and regional differences will reflect both differences in epidemiology and in case 
ascertainment. For example, the apparent force of infection for sheep may be much higher than for 
cattle because the lambing season coincided with the period when SBV was circulating. In addition, 
sheep flocks tend to be larger than cattle herds and so have a greater chance of having a case.  
 
Figure 7.5:   Marginal posterior densities for hierarchical parameters in models for the incidence of 
SBV-affected cattle and sheep holding within NUTS2 regions. (a,b) Estimated force of infection based 
on the number of cattle and sheep holdings within a region reporting AHS cases: (a) mean and (b) 
scale  parameter  in  hierarchical  distribution  for  cattle  (solid  line)  and  sheep  (dashed  line).  (c-f) 
Parameter estimates based on the number of cattle and sheep holdings within a region reporting AHS 
cases  and  on  serological  surveys  (Belgium  and  the  Netherlands  only).  (c,d)  Estimated  force  of 
infection: (c) mean and (d) scale parameter in hierarchical distribution for cattle (solid line) and sheep 
(dashed line). (e,f) Mean proportion of (e) cattle or (f) sheep holdings affected by SBV experiencing 
and reporting AHS cases. 
For Belgium and the Netherlands it was possible to adjust the estimates for the force of infection to 
allow for under-ascertainment, because a second, independent source of data on SBV occurrence is 
available  (in  this  case  data  from  serological  surveys;  Méroc  et.  al.,  2013a,b;  Veldhuis  et.  al., 
2013).There were still differences in the force of infection between cattle and sheep holdings, though 
the difference was much smaller (Fig. 7.5c). There were also differences amongst regions in the force 
of infection for both species. Under-ascertainment of SBV-affected holdings was much higher in cattle 
compared with sheep farms. We estimated that 0.5 % of affected cattle holdings reported AHS cases 
(Fig. 7.5e), whereas 2 % of affected sheep holdings reported AHS cases (Fig. 7.5f). Two factors could 
help explain this difference between species. First, calving tends to occur all year round (at least when Schmallenberg virus: State of Art 
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aggregated at a regional level) while lambing tends to be much more strongly seasonal. Second, calves 
infected in utero can clear SBV infection (and so may not be confirmed as SBV cases), while lambs 
cannot  (De  Regge  et.  al.,  2013).  However,  extrapolating  these  estimates  to  other regions  will  be 
complicated because under-ascertainment of AHS cases in a region will depend on the seasonality of 
lambing and calving and the time of introduction of SBV, as well as other factors such as farmer 
willingness to report. 
8.  Impact Assessment 
A considerable level of under ascertainment has been estimated in relation to the SBV epidemic in the 
EU (EFSA, 2012a), this renders the assessment of the infection impact very difficult. A small number 
of studies based on active or passive surveillance have now been published which attempt to measure 
the impact of the disease or provide data likely to be useful for estimating the impact of the disease; 
these are also discussed below. The impact of the infection can be described as: 
Direct impact on adult animals 
Clinical signs of acute SBV infection in adult animals include fever and diarrhoea and decreased milk 
production in low proportion of infected animals. Typically, full recovery occurs within a few days. At 
herd  or  regional  level  reduction  on  production  features  such  as  fertility  efficiency  has  also  been 
demonstrated (Veldhuis, et. al., 2014).  
Direct impact on foetuses/newborn animals 
The  offspring  of  animals  infected  with  SBV  during  certain  stages  of  pregnancy  are  at  risk  of 
complications including deformation and abortion. At regional and national level impact has been 
demonstrated to be relatively low (Afonso et. al., 2014). At a farm level, this impact is highly variable 
and is likely to depend on the calving or lambing programme used. Farms adopting calving or lambing 
patterns which result in the at-risk period falling mostly or entirely during the periods of low vector 
activity  (approximately  December-March)  are  likely  to  experience  much  lower  impact  than  those 
adopting calving or lambing patterns which result in the at-risk period coinciding with a period of high 
vector activity, for example August-September (see Section 4.1). 
Indirect impacts 
Other consequences of SBV infection which are likely to have had a significant impact include trade 
restrictions and costs related with treatments or for example expenses related with complications at 
calving and lambing.  
8.1.  Studies on impact  
8.1.1.  Impact on dairy farms 
Veldhuis  et.  al.,  (2014)  report  an  analysis  of  various  productivity  parameters  including  milk 
production, reproductive performance and mortality from dairy herds in Germany and the Netherlands 
during the SBV transmission period compared to a pre-SBV reference period, which shows a probable 
effect  of  SBV  infection  on  abortion,  shorter  gestation,  non-return  and  the  number  of  artificial 
inseminations required per animal. Overall, average production between August 15
th and September 
19
th 2011 was 0.26kg per day, per cow lower than the same period in 2009-2010. In herds which 
notified malformations in newborn calves during this period, production was 0.43kg lower. 
Veldhuis et. al., (2014) also mention anecdotal reports of reduced fertility in dairy cattle, and Brouwer 
et. al., (2012) note that the number of samples submitted to the Dutch national abortion monitoring 
system during the last quarter of 2012 was elevated. Schmallenberg virus: State of Art 
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Wernike et. al. (2013c) presented the study of a farm located near the city of Schmallenberg closely 
monitored between May 2011 and January 2012 in the context of tick-borne fever surveillance. The 
animals in the farm (58 dairy cows, their offspring and two breeding bulls) were kept until the end of 
the study and no animals were introduced. Every tested animal resulted negative to SBV up to week 
37 of 2011 and after week 41 all tested samples were positive, and no abnormalities such as decrease 
milk  yield  or  diarrhoea  were  observed,  while  fever  was  reported.  It  was  also  reported  that  not 
premature, stillbirth or birth of malformed calves was observed despite the fact that at the end of 
September  2011  12  of  the  tested  cows  were  pregnant  between  days  75  and  175  of  gestation 
(presumably the critical period). 
8.1.2.  Impact on beef farms 
No data are available for beef farms. 
8.1.3.  Impact on sheep farms 
Dominguez et. al., (2012) report a study of the impact of Schmallenberg virus in France based on 
lambing records from 362 SBV-positive flocks in 28 districts. In most cases (76 % of flocks for which 
data were available), the mating period started between early August 2011 and mid-September 2011, 
during a period when the Culicoides vectors of SBV were likely to be active. 
This study suggests that 85 % of ewes (34,470) gave birth at full term to only healthy lambs. Of the 
15 % of ewes that had lambing problems, 72 % (11 % of the total) gave birth at full term but at least 
one of their lambs was stillborn, born deformed or died within 12 hours of birth, and the remainder 
aborted. Furthermore, of the 15 % of ewes that had lambing problems, 12 % (2 % of the total) died 
within 15 days of delivery. 
Extrapolation of  these  data  to  estimate  the broader impact  of  SBV across  the  affected  regions is 
complicated by a lack of data on seroprevalence within the farms in the survey. Moreover the authors 
recognise that the imputability of SBV virus in the occurrence of the lambing problems, or in the death 
or deformities reported in lambs was not assessed and could therefore be due to other concurring 
causes. 
Saegerman et. al., (2013) report a preliminary survey comparing 13 positive (by RT-qPCR) flocks 
with  13  negative  flocks  (flocks  on  which  no  clinical  signs  consistent  with  SBV  were  observed). 
Several characteristics were present more frequently in the positive flocks, including an increased rate 
of abortions (6.7 % vs 3.2 %), malformed full-term lambs (10.1 % vs. 2.0 %), and complications in 
labour (10.1 % vs. 3.4 %).  
Another study was conducted in the Netherlands (EC, 2014) to identify and quantify flock level risk 
factors for malformations in newborn lambs caused by SBV, as well as to describe the effect on 
mortality and reproductive performance. It was concluded that significantly higher mortality rates 
before weaning were observed in case flocks, as well as an increase of repeat breeders compared to the 
lambing period preceding the introduction of SBV. Clinical signs were reported as limited in adult 
animals. The impact for the entire sheep industry in the Netherlands was reported to be very limited. 
8.1.4.  Impact on goat farms  
No data are available for goat farms. 
8.2.  Estimation of indirect impact 
It is likely that, the principle economic impact of SBV has been felt via international trade restrictions. 
In particular cattle semen trade has been restricted in several countries, in terms of percentage of total 
semen trade, most of the trade happen within EU (2010: 73.4 % and 2011: 82.8 %), from the semen 
trade  outside  EU  (2010:  26.6 %  and  2011:  17.2 %),  around  60 %  of  those  are  trade  with  those 
countries imposing restrictions, representing for 2010 a 15.1 % of the total EU semen trade and for Schmallenberg virus: State of Art 
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2011 only 10.9 %. In normal years, the EU Member States are exporting between 10 and 12 million 
doses  of  bovine  semen  to  third  countries.  However,  in  2012  the  trade  problems  due  to  the 
Schmallenberg  virus  caused  a  decline  to  8.9  million  doses  (a  decline  of  between  11  and  26 %). 
Previously, deliveries to Third countries made up for 55 % to 60 % of overall trade, but that figure 
declined to just over 40 % in 2012. As for the pure-bred breeding animals, the official statistics 
(EUROSTAT) show that the export value dropped from almost 590 million Euros in 2011 (heifers, 
cows and other breeding animals) to 475 million Euros in 2012 (a decline of 20 %). The 28 EU 
Member States sold around 303.000 animals in 2012, thereof 120.000 to Third countries (more than 
94 % of the total are heifers; source EXPLA Platform; http://www.adt.de/expla_fr.html).  
8.3.  Expected future impact of SBV 
The impact of the SBV epizootic consists of direct impact (abortion, infertility) and indirect impact 
(international trade restrictions). The direct impact observed during 2012 resulted from the spread of 
SBV into a completely naïve host population. It is therefore likely to represent a worst-case scenario 
which is unlikely to be repeated; if SBV remains endemic in Europe (immunity will continue to be 
present in a fraction of the host population indefinitely). However, the incidence of SBV infection may 
vary between years. The duration and amplitude of interannual epidemic cycles will depend on the rate 
at which susceptible hosts enter the population, which in turn will depend on restocking rates, the level 
of vaccine use and the durations of immunity following natural infection and vaccination. In the 
absence of data on several of these variables, it is not possible to estimate the future direct impact of 
SBV and the extent to which this will vary between years. 
In the event that Europe becomes SBV free, the population level of immunity will decline. Subsequent 
reintroduction of SBV in Europe could then result in an outbreak of similar magnitude to that seen in 
2012. 
The future indirect impact of SBV will depend on the position adopted by the international community 
with respect to trade restrictions applied to export from SBV-affected countries.  
Farmers have the opportunity to mitigate the direct impact of SBV by vaccinating their animals, or by 
ensuring that animals are not in the at-risk period of pregnancy during the high vector activity season. 
Similar  strategies  have  been  proposed  to  deal  with  other  viruses  such  as  Akabane  in  Australia 
(http://www.daff.qld.gov.au/animal-industries/animal-health-and-diseases/a-z-list/akabane).  
CONCLUSIONS 
Metagenomic  analysis  of  animal  material  allowed  the  rapid  identification  of  SBV  is  a  newly 
discovered orthobunyavirus, related to viruses in the Simbu serogroup, as the cause of the new disease 
that emerged in 2011. The availability of the (almost) complete nucleotide sequence of the SBV 
genome enabled a genetic test for SBV to be developed and distributed throughout Europe. It also 
contributes to the establishment of reverse genetic systems that will facilitate further research on SBV 
molecular  biology,  pathogenesis  and  vaccine  development.  Wide-scale  sequencing  studies  on 
orthobunyaviruses would have helped to more quickly understand the relationship between SBV and 
extant Simbu serogroup viruses.  
SBV RNA or antibodies have been detected in domestic cattle, sheep and goats and also in another 12 
wild species: Alpacas, Anatolian water buffalo, Elk, Bison, Red deer, Fallow deer, Roe deer, Sika 
deer, Muntjac, Chamois, Wild boar and Dogs, as well as in 19 zoo species. The seroprevalence studies 
in cattle, sheep and goats indicate that SBV has probably spread over the whole of Europe. According 
to the seroprevalence studies conducted at national scale, prevalence at animal and herd levels were in 
general high, while variables between regions within a country.  
The number of herds with SBV confirmed AHS (arthrogryposis hydranencephaly syndrome) cases 
compared to the level of infection indicated by seroprevalence studies, suggest that the frequency of 
clinical disease is low. Experimental infection studies on pregnant ewes and cows suggest that SBV Schmallenberg virus: State of Art 
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rarely induces malformations, although the presence of viral RNA can be demonstrated in the placenta 
and foetuses of some ewes and cows.  
Limited numbers of articles have reported the risks of transmission of orthobunyaviruses via semen 
and embryos. Recent data indicate that SBV may be detected in semen samples with a low frequency. 
However, there is no scientific evidence of transmission through insemination. This is in agreement 
with epidemiological data, which indicate that the vector transmission remains the principal route 
explaining the dissemination of such viruses, details are given below.  
Phylogenetic relations of SBV with viruses of the Simbu serogroup led to suspicion that SBV was 
transmitted  by  Culicoides.  Vector  competence  studies  in  Culicoides  nubeculosus  colony  lines 
demonstrated the ability of Culicoides to replicate SBV to a transmissible level after intrathoracic 
inoculation  and  oral  exposure.  Studies  of  field  collected  Culicoides  confirmed  C.  obsoletus,  C. 
scoticus and C. chiopterus as highly probable vectors of SBV in northern Europe. In addition, C. 
dewulfi,  C.  pulicaris,  C.  nubeculosus,  C.  imicola  and  C.  punctatus  were  implicated  as  suspected 
vectors. Taken in their entirety,  these  studies  convincingly  implicated  a range  of  widespread  and 
abundant  farm-associated  Culicoides  species  in  the  transmission  of  SBV.  Studies  of  vector 
competence  provide  preliminary  evidence  that  mosquitoes  do  not  play  a  substantial  role  in 
transmission of SBV in the field.  
There is no evidence yet that vertical transmission is a major route of transmission of SBV. SBV has 
been detected in certain tissues of clinically-affected newborn calves, kids and lambs but neither SBV 
virus  nor  RNA  has  been  documented  in  their  blood.  Therefore,  clinically  affected  newborns  are 
unlikely to be source of virus for vectors. There is limited evidence for the transmission of SBV to 
progeny Culicoides.  
SBV has successfully overwintered, despite lengthy period of minimal vector activity. The mechanism 
is unknown at present; however vertical transmission in host or vector may play a role.  There is no 
evidence of persistent infection in the host. 
There are only limited data on duration of immunity in cattle and none on the duration of immunity in 
sheep. The data for cattle suggest that immunity lasts for at least one year following natural infection. 
A model for the farm to farm spread of a vector borne virus parameterized for SBV show a rapid 
spread of infection across the study region. Changes to four epidemiological parameters (latent period, 
duration  of  viraemia,  probability  of  transmission  from  host  to  vector  and  virus  replication)  are 
sufficient to account for the rapid SBV spread within and between farms relative to that seen for BTV-
8.  This  suggests  that  alternative  transmission  mechanisms  (for  example,  direct  transmission  or 
additional vector species) are not necessary to explain the observed patterns of spread of SBV, though 
they may still play a minor role. The enhanced between-farm transmission of SBV brought about by 
these  four  parameters  is  such  that  the  application  of  movement  restrictions,  even  a  total  animal 
movement ban, has little effect on the spread of SBV (relative reduction around 4 %).  
The ability to estimate impact of Schmallenberg virus was restricted by the limited availability of data; 
studies conducted reported a probable effect of SBV infection on abortion, short gestation, non-return 
and the number of artificial inseminations required per animal. The principle economic impact of SBV 
has been felt via international trade restrictions, particularly in live animals and semen. 
RECOMMENDATIONS 
Complete genome sequences of Simbu serogroup viruses from multiple geographical locations, in 
particular,  detection,  isolation and  genetic  characterisation of  Simbu  serogroup  viruses,  should  be 
obtained to understand relationships between these viruses and to help understand the origin of SBV.  Schmallenberg virus: State of Art 
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Characterisation  of  genetic  variation  within  SBV isolates  across  Europe  should  be  continued and 
correlated with the ability of serum from vaccinated animals to neutralise these isolates to confirm that 
available vaccines continue to be efficacious. 
Measurement of the duration of immunity in both naturally infected and vaccinated animals should be 
undertaken  to  understand  the  likely  continuing  impact  of  the  outbreak  and  inform  vaccination 
strategies. 
Membrane-based techniques should be developed for northern European Culicoides species, with the 
aim to standardize vector competence studies of field collected Culicoides populations against SBV, 
this will allow more accurate identification of vector species.  
Vertical transmission studies should be undertaken, both in host and vectors, in order to understand 
overwintering mechanisms and assess risk from trade in live animals. 
Studies on vector activities during the winter periods (period of lower temperatures in Europe) should 
be conducted in order to complement our understating of vector role in SBV epidemics. 
Access  to  data  readily  available  is  required  to  improve  assessment  of  Schmallenberg  virus 
transmission and any other novel diseases entering in Europe: 
  Herd size information 
  Locations of herds at least at NUTS3 regions 
  Monthly  animal  movements  (number  of  animals)  preferably  between  NUTS3  regions  in 
Europe, but should be available at least for NUTS2 
Access to data readily available is required to improve assessment of Schmallenberg virus impact and 
future novel diseases incursions in Europe: 
  Monthly milk production at NUTS3 level 
  Mortality  in  adult  female  for  cattle  and  sheep  due  to  complication  related  to  delivery  in 
targeted herds 
  Number of new born calves and lambs per month, stillbirths, number of abortions for both 
species preferably at herd level, but at least information at NUTS3 should be available 
  Total number of tested herds at NUTS3 level 
In order to increase preparedness for new disease threats: 
  Development of experimental protocols to facilitate measurement/estimation of transmission 
parameters involved in transmission and spread models 
  Further research on potential control strategies for vector borne diseases Schmallenberg virus: State of Art 
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APPENDICES 
Appendix A.   Seroprevalence Studies 
Ref. ID  Citation  Coverage  Study Design  Sample Units  Laboratory Testing  Prevalence  Strengths and Weaknesses 
1  Azkur  A.K,  Harun  Albayrak, 
Ali  Risvanli,  Zuleyha  Pestil, 
Emre  Ozan,  et.  al.,  2013 
Antibodies  to  Schmallenberg 
virus  in  domestic  livestock  in 
Turkey Tropical Animal Health 
and  Production  DOI 
10.1007/s11250-013-0415-2 
Turkey  (3 
regions) 
 
2006 - 2013 
Retrospective  analysis  of  
serum samples from animals at 
slaughter 
Cattle = 816 
Sheep= 307 
Goats  =  109 
Anatolian  water 
buffalo= 130 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 60% 
Percentage seropositive 
 
Cattle = 325/816 (39.8 %) 
Sheep  =  5/307 (1.6 %) 
Goats  = 3/109 (2.8 %) 
Anatolian  water  buffalo  = 
2/130 (1.5 %) 
Wide area coverage, but sample may 
not be representative 
 
No second confirmatory test (VNT or 
SNT)  -  cross  reactivity  may  lead  to 
false positives 
 
Seroprevalence  a  simple  ratio  of 
positive/tested 
No  consideration  of  intra-class 
correlation 
2  Chaintoutis  SC,  Kiossis  E, 
Giadinis  Nd,  Brozos  Cn, 
Sailleau C, Viarouge C, Bréard 
E,  Papanastassopoulou  M, 
Zientara  S,  Papadopoulos  O, 
Dovas  CI.  2013.  Evidence  Of 
Schmallenberg  Virus 
Circulation  In  Ruminants  In 
Greece. Trop Anim Health Prod. 
2013  Jul  19.  [Epub  Ahead  Of 
Print]. 
Greece (1 region) 
 
March 2013 
Outbreak investigation  
 
Random sample animals within 
herd 
 
Stratification  by  origin  of 
animal 
Cattle=90  (3 
herds) 
 
Sheep  =  57  (3 
herds) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Cut-off not reported 
 
SNT  confirmatory 
testing of positives 
Within herd seroprevelance 
 
Cattle  range    30.0  %  - 
86.7% 
 
Sheep 1 positive animal in 
two flocks 
 
Low sample size - lack of precision 
Sample may not be representative 
 
Second  confirmatory  test  (VNT  or 
SNT) included 
 
Herds  selected  on  basis  of  clinical 
signs 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
3  Elbers  ARW,  Loeffen  WLA, 
Quak S, de Boer-Luijtze E, van 
der Spek AN, Bouwstra R, Maas 
R,  Spierenburg  MAH,  de 
Kluijver EP, van Schaik G and 
van  der  Poel  WHM,  2012. 
Seroprevalence  of 
Schmallenberg Virus Antibodies 
among  Dairy  Cattle,  the 
Netherlands, Winter 2011-2012. 
Emerging  Infectious  Diseases, 
18,  1065-1071.  Available  from 
<Go  to 
ISI>://WOS:000306034600005. 
Netherlands  
 
November  2011–
January 2012 
Retrospective  analysis  of  
serum  samples  for  BTV 
programme and sentinel herds 
 
Random  sample  of  animals 
with serum samples 
 
Stratification by region 
 
Expected  prevalence  =  50%  
(maximum allowable error 
≈3%) 
Dairy  Cattle 
=1,123  
(489 herds) 
 
Sheep flock1=60 
Sheep flock2=35 
 
Cattle herd1=34 
Cattle herd2=34 
VNT Loeffen 
et. al., (2012) 
 
Titers  >8  were 
considered positive -  
specificity  and 
sensitivity 
of  >99%  were 
estimated  with  this 
cut-off 
Estimated seroprevalence  
Dairy  cattle  72.5%  (95% 
CI 69.7%–75.1%). 
 
Within herd seroprevalence 
Dairy  cattle  range  73.5%, 
95%  CI  55%–87%)  - 
100%,  95%  CI  87%–
100%).  
 
Sheep  range  71.4%,  95% 
CI 
52%–85%) - 93.3%, 
95% CI 82%–98%) 
 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
Herds  selected  on  basis  of  clinical 
signs 
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4  Gache  K,  Dominguez  M, 
Pelletier C, Petit E, Calavas D, 
Hendrikx  P  and  Touratier  A, 
2013.  Schmallenberg  virus:  a 
seroprevalence  survey  in  cattle 
and sheep, France, winter 2011–
2012.  Veterinary  Record,  173, 
141-141. 
France  
 
Winter 2011-2012 
 
 
Retrospective  analysis  of  
serum  samples  for  Brucellosis 
or IBR programme  
 
Voluntary  samples  at  holding 
level,  random  selection  of 
animals within holding 
 
Stratification by outbreak status 
- No congenital SBV outbreak 
(Category 1), departments with 
1–20  outbreaks  (Category  2) 
and  departments  with  more 
than 20 outbreaks (Category 3) 
 
Expected prevalence = 7% 
Sheep = 3007 (77 
holdings)  
 
Cattle=3252  (78 
holdings)  
 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Cut-off not reported 
Within herd seroprevalence 
for  herds  in  Category  3 
departments  with  more 
than 20 outbreaks 
 
Cattle median = 90% 
Sheep median = 30% 
 
 
 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Sample may not be representative 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
Seroprevalence estimate using simple 
ratio of positive/tested 
4  Gache  K,  Dominguez  M, 
Pelletier C, Petit E, Calavas D, 
Hendrikx  P  and  Touratier  A, 
2013.  Schmallenberg  virus:  a 
seroprevalence  survey  in  cattle 
and sheep, France, winter 2011–
2012.  Veterinary  Record,  173, 
141-141. 
France (1 region)  
 
Winter 2011-2012 
 
Retrospective  analysis  of  
serum  samples  from  IBR 
programme  
 
Voluntary  samples  at  holding 
level,  random  selection  of 
animals within holding 
 
Stratification by region 
Cattle  =  1525 
(343 holdings) 
 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Cut-off not reported 
Seroprevalence  
Cattle range 8% - 84% 
 
Sample may not be representative 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
Seroprevalence estimate using simple 
ratio of positive/tested 
No  consideration  of  intra-class 
correlation 
 
 
 
5  Garigliany  M-M,  Bayrou  C, 
Kleijnen  D,  Cassart  D  and 
Desmecht  D,  2012. 
Schmallenberg  Virus  in 
Domestic  Cattle,  Belgium, 
2012.  Emerging  Infectious 
Diseases,  18  (6),  1512-1514. 
Available  from  <Go  to 
ISI>://WOS:000307989700023. 
Belgium 
 
February  13–
April 22, 2012 
Seroprevalence study 
 
Random  sample  of  cow/calf 
pairs 
 
 
Cow/calf  pairs 
=519  (209 
holdings) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect  
 
Positive S/P > 70% 
 
 
Apparent  seroprevalence  
adult  cows    90.8%  (95%, 
CI 88.3–93.2 
 
Calves born to seropositive 
cows,  116/471  (24.6% 
95% CI 20.7–28.5) 
 
Low sample size - lack of precision 
 
Insufficient  information  on  study 
design 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
Seroprevalence estimate using simple 
ratio of positive/tested Schmallenberg virus: State of Art 
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6  Helmer C, Eibach R, Tegtmeyer 
PC, Humann-Ziehank E, Ganter 
M,  2013.  Survey  of 
Schmallenberg  virus  (SBV) 
infection in German goat flocks, 
Epidemiol Infect Mar 18:1-11. 
Germany  (6 
regions) 
 
January-  June 
2012 
Seroprevalence study 
 
Stratification by region 
 
Random  sample  of  herds  and 
animals 
 
Expected prevalence = 20% 
 
 
Adult  female 
goats  =  1065  (>1 
year) (40 herds) 
 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 70% 
Between  herd 
seroprevalence 
Goats = 38/40 (95%)  
 
Within herd seroprevalence 
Goats range 3.3% - 93.3% 
median 36.7% 
 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Within herd sample size requirement 
result in bias towards larger herds 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
 
7  Kaba  J,  Czopowicz  M, 
Witkowski  L,  2013. 
Schmallenberg  virus  antibodies 
detected  in  Poland. 
Transboundary  and  emerging 
diseases.  60,  1-3,  doi: 
10.1111/tbed.12039 
Poland  (3 
regions) 
 
24 - 30 July 2012 
Serology Survey 
 
Stratification by region 
 
Targeted  sample  based  on 
proximity to Polish border 
 
Expected prevalence = 5% 
 
 
Adult goats = 230  IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 60% 
Percentage  seropositive  in 
region 
Goats range 2% - 16% 
 
 
Sample may not be representative 
 
No second confirmatory test (VNT or 
SNT)  -  cross  reactivity  may  lead  to 
false positives 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
 
8a  Méroc E, De Regge N, Riocreux 
F, Caij AB, van den Berg T and 
van  der  Stede  Y,  2013b. 
Distribution  of  Schmallenberg 
Virus  and  Seroprevalence  in 
Belgian  Sheep  and  Goats. 
Transboundary  and  Emerging 
Diseases,  doi: 
10.1111/tbed.12050 
Belgium 
 
November 2011 - 
April 2012 
Retrospective  analysis  of  
serum  samples  from  Maedi-
Visna and Caprine Arthritis and 
Encephalitis Programme 
 
Voluntary samples  
 
Expected prevalence = 90–95%  
(accepted error of 5%) 
Sheep = 1082 (83 
herds) 
 
Goats  =142  (8 
herds) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 60% 
Estimated  within  herd 
seroprevalence 
 
Sheep  84.31%  (95%  CI: 
84.19–84.43) 
Goats  40.68%  (95%  CI: 
23.57–60.4%) 
 
Between  herd 
seroprevalence  Sheep 
98.03%  (95%  CI:  97.86–
98.18) 
 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Within herd sample size requirement 
result in bias towards larger herds 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
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8b  Méroc E, Poskin A, Van Loo H, 
Quinet  C,  Van  Driessche  E, 
Delooz  L,  Behaeghel  I, 
Riocreux  F,  Hooyberghs  J,  De 
Regge  N,  Caij  AB,  van  den 
Berg T, van der Stede Y, 2013a. 
Large-Scale  Cross-Sectional 
Serological  Survey  of 
Schmallenberg Virus in Belgian 
Cattle  at  the  End  of  the  First 
Vector  Season.  Transbound 
Emerg  Dis.  doi: 
10.1111/tbed.12042.  
Belgium 
 
2  January  -  7 
March 2012 
Retrospective  analysis  of  
serum  samples  for  BTV  and 
IBR programme 
 
Random sample of herds 
 
Stratification by region at herd 
level and by age at animal level 
Cattle  =  11  635  
(422 herds) 
 
  
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 60% 
Estimated  within  herd 
seroprevalence 
 
Cattle  86.3%  (95%  CI: 
84.75–87.71) 
 
Between  herd 
seroprevalence  Cattle 
99.76%  (95%  CI:  98.34–
99.97)  
Sample  size  allows  estimation  at 
design prevalence 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
 
Within herd sample size requirement 
result in bias towards larger herds 
 
 
8c  Méroc E, Poskin A, Van Loo H, 
Van  Driessche  E,  Czaplicki  G, 
Quinet  C,    Riocreux  F, 
Hooyberghs J, De Regge N, Caij 
AB,  van  den  Berg  T, 
Hooyberghs  J,  and  van  der 
Stede  Y,  2013c.  Follow-up  of 
the  Schmallenberg  Virus 
Seroprevalence  in  Belgian 
Cattle.  Transbound  Emerg  Dis. 
doi: 10.11 11/tbed. 12202 
Belgium  
1
st January – 28th 
February 2013 
Serology survey 
 
Stratified by region and age 
 
Expected  prevalence  =  90% 
(accepted error of  5%) 
Cattle  =  7130  ( 
188 herds) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 60% 
4470 positive samples (all 
herds  had  at  least  one 
positive animal) 
 
Mean  within-herd 
seroprevalence  65.66%  ( 
95% CI: 62.28-69.04) 
Sample  size  allows  estimation  at 
design prevalence 
 
The doubtful results are considered as 
positive in the data analysis. 
 
Seroprevalence  estimated  using 
generalized estimating equations 
 
9  Nanjiani IA, Aitken P, Williams 
P,  2013.  Prevalence  of 
seropositive sheep within flocks 
where  Schmallenberg  Virus 
infection  was  suspected  or 
confirmed.  Veterinary  Record 
doi: 10.1136/vr.101796. 
United  Kingdom 
(5 regions) 
 
December  2012- 
January 2013 
 
 
Voluntary herd selection 
Survey 
 
Voluntary samples 
 
Expected  prevalence  =  10%  
(Error 4.8-11.7) 
Sheep  =  594  (10 
herds) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Positive S/P > 70% 
Percentage seropositive  
 
Sheep range  8.5 - 73.3 per 
cent  (95  per  cent 
confidence 
limits  as  low  as  3.7  per 
cent,  and  as  high  as  82.9 
per cent) 
Low sample size - lack of precision 
 
Sample may not be representative 
 
Seroprevalence estimate using simple 
ratio of positive/tested 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
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10  Veldhuis  AMB,  van  Schaik  G, 
Vellema  P,  Elbers  ARW, 
Bouwstra  R,  van  der  Heijden 
HMJF  and  Mars  MH,  2013. 
Schmallenberg  virus  epidemic 
in  the  Netherlands: 
Spatiotemporal  introduction  in 
2011  and  seroprevalence  in 
ruminants.  Preventive 
Veterinary  Medicine,  112,  35-
47.  Available  from 
http://www.sciencedirect.com/sc
ience/article/pii/S016758771300
2092. 
Netherlands 
 
November 2011 -
March 
2012 
Retrospective  analysis  of  
serum  samples  from  IBR 
programme 
 
Random sample 
 
Expected  prevalence  =  50%  
(maximum allowable error 
≈8%) 
Cattle,  non-dairy 
=  1373  (276 
herds) 
 
 
ELISA  (Van  der 
Heijden et. al., 2013)  
 
sensitivity  of  98.8% 
(95%  confidence 
interval  (CI):  93.3–
99.8) and a specificity 
of  98.8%  (95%  CI: 
97.5–99.6). 
 
Positive S/P > 15% 
 
Estimated seroprevalence 
 
Non dairy cattle 98.5%  
 
Between  herd 
seroprevalence 
Non  dairy  cattle  99.3% 
(95% CI: 97.4–99.9) 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
 
Within herd sample size requirement 
result in bias towards larger herds 
 
 
 
10  Veldhuis  AMB,  van  Schaik  G, 
Vellema  P,  Elbers  ARW, 
Bouwstra  R,  van  der  Heijden 
HMJF  and  Mars  MH,  2013. 
Schmallenberg  virus  epidemic 
in  the  Netherlands: 
Spatiotemporal  introduction  in 
2011  and  seroprevalence  in 
ruminants.  Preventive 
Veterinary  Medicine,  112,  35-
47.  Available  from 
http://www.sciencedirect.com/sc
ience/article/pii/S016758771300
2092. 
Netherlands 
 
November 2011 -
March 
2012 
Retrospective  analysis  of  
serum  samples  from  BTV 
programme 
 
Random sample 
 
Stratification by region 
 
Expected  prevalence  =  50%  
(maximum allowable error 
≈8%) 
Dairy  Cattle  = 
3066 (247 herds) 
 
 
ELISA  (Van  der 
Heijden et. al., 2013)  
 
sensitivity  of  98.8% 
(95%  confidence 
interval  (CI):  93.3–
99.8) and a specificity 
of  98.8%  (95%  CI: 
97.5–99.6). 
 
Positive S/P > 15% 
 
Estimated seroprevalence 
 
Dairy heifers 63.4% 
 
Between  herd 
seroprevalence 
Dairy  cattle  95.5%  (95% 
CI: 92.3–97.7)  
 
 
 
Sample  size  allows  estimation  at 
design prevalence 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
 
Within herd sample size requirement 
result in bias towards larger herds 
 
Regional or temporal variability may 
be  due  to  seroconversion  ongoing 
during the study 
 
 
10  Veldhuis  AMB,  van  Schaik  G, 
Vellema  P,  Elbers  ARW, 
Bouwstra  R,  van  der  Heijden 
HMJF  and  Mars  MH,  2013. 
Schmallenberg  virus  epidemic 
in  the  Netherlands: 
Spatiotemporal  introduction  in 
2011  and  seroprevalence  in 
ruminants.  Preventive 
Veterinary  Medicine,  112,  35-
47.  Available  from 
http://www.sciencedirect.com/sc
ience/article/pii/S016758771300
2092. 
Netherlands 
 
November 2011 -
March 
2012 
Retrospective  analysis  of  
serum  samples  from  Brucella 
melitensis  and    maedi-visna 
virus  or  caprine  arthritis 
encephalitis virus programme 
 
Voluntary and random samples 
 
Stratification by region 
 
Expected prevalence = 30% or 
higher 
Sheep  =    2876 
(344 herds) 
 
Goats  =    1553 
(185 herds) 
 
ELISA  (Van  der 
Heijden et. al., 2013)  
 
sensitivity  of  98.8% 
(95%  confidence 
interval  (CI):  93.3–
99.8) and a specificity 
of  98.8%  (95%  CI: 
97.5–99.6). 
 
Positive S/P > 15% 
Estimated seroprevalence 
Sheep 89.0%  
Goats 50.8%  
 
Between  herd 
seroprevalence  
Sheep 97.1% (94.7–98.6) 
Goats  81.1%  (95%  CI: 
74.7–86.5) 
Sample  size  allows  estimation  at 
design prevalence 
 
Seroprevalence  estimated  using 
generalized estimating equations 
Estimation of intra-class correlation 
 
Sample may not be representative Schmallenberg virus: State of Art 
 
EFSA Journal 2014;12(5):3681  49 
11  Chenais E, Ståhl K, Frössling J, 
Blomqvist  G,  Näslund  K, 
Svensson  L,  Renström  L, 
Mieziewska  K,  Elvander  M, 
Valarcher  JF.,  2014. 
Schmallenberg  Virus  beyond 
Latitude  65°N.  Transbound 
Emerg  Dis.  2013  Dec  11.  doi: 
10.1111/tbed.12195.  [Epub 
ahead of print] 
Sweden 
 
August  2011  – 
May 2013 
Six  hundred  sera  from  sheep 
were  collected  between  1 
August  2011  and  31  March 
2012  from  150  herds,  and 
selected  among  samples 
originally  collected  within  the 
Swedish  surveillance 
programme  for  Maedi/Visna. 
Bulk milk survey in cattle was 
conducted  before  and  after 
vector season of 2012 
 
Sheep = 600 (150 
herds) 
Bulk  milk  from 
641 and 723 dairy 
farms 
Rsik  based 
surveillance  from 
67  herds  (30 
cattle, 34 sheep, 2 
alpaca and 1 goat) 
An  indirect  in-house 
SBV  ELISA  was 
developed (K. 
Näslund,  G. 
Blomqvist,  C. 
Vernersson,  S. 
Zientara, E. 
Breard  and  J.  F. 
Valarcher,  in 
preparation). 
Commercially 
available indirect SBV 
ELISA (ID Screen 
Schmallenberg  virus 
Milk  Indirect  ELISA; 
IDvet, Grabels, 
France), VNT and RT-
PCR 
Reported  number  of 
positive  herds  for  sheep 
and cattle per month from 
November 2012 until May 
2013. 
Reported different levels of 
S/P  ratio  for  bulk  milk 
after vector season. 
The different serological surveys were 
conducted; each designed to detect a 
prevalence  of  SBV  infection  at 
approximately  2%  and  with  at  least 
95%  confidence,  but  not  details  are 
given  on  how  it  was  calculated. 
Population  is  hierarchical  in  nature 
and  variability  at  herd  and  animal 
levels are not mentioned. 
12  Steinrigl  A,  Schiefer  P, 
Schleicher  C,  Peinhopf  W, 
Wodak  E, Bagó  Z,  Schmoll  F, 
2014.  Rapid  spread  and 
association  of  Schmallenberg 
virus  with  ruminant  abortions 
and  foetal  death  in  Austria  in 
2012/2013. Prev Vet Med. DOI: 
10.1016/j.prevetmed.2014.03.00
6 
July  –  December 
2012 
Samples  were  collected  in  the 
context of national Bluetongue 
monitoring  program,  national 
screening  programme  for 
Bovine  brucellosis,  Enzootic 
bovine  leucosis  and  Infectious 
bovine rhinotracheitis, national 
Brucella  melitensis  screening 
programme  as  well  as  private 
commissions  and  samples  link 
to abortions. 
Cattle  =  2113 
(801  herds), 
Initially  samples 
for Sheep = 1031 
and  Goat  =  230, 
from  which  in 
total  only  830 
were  used  (248 
herds) 
IDvet  ELISA,  ID 
Screen® 
Schmallenberg  virus 
indirect 
 
Temporal  and  regional 
differences  were  tested. 
For  cattle  temporal 
differences were identified, 
while  for  shep  and  goats 
both temporal and regional 
differences were found. 
This study is one of the few to analyze 
the dynamics of SBV spread in cattle 
for  a  whole  country.  The  sampling 
strategy applied for this study cannot 
exclude bias coming from unbalanced 
temporal  or  spatial  sampling  design, 
because samples were compiled from 
different  screening  programmes  in 
order  to  allow  sufficient  monthly 
coverage. 
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Appendix B.   Other Susceptible Species 
Citation  Species found  Clinical 
signs 
Laboratory Testing  Strengths  and 
Weaknesses 
Schmallenberg virus „still circulating in the UK 
Veterinary Record, 2012 171:140 
doi: 10.1136/vr.e5373 
Alpacas (Vicugna pacos)  None 
recognised 
Detection  of  antibodies  in  two 
animals in a very small flock 
 
 
The specie is not closely 
related  to  sheep  or 
goats,  but  very  little 
detail  about  study 
design used is given 
Jack, C, O. Anstaett, J. Adams, R. Noad and J. Brownlie, 2012: 
Evidence of seroconversion to SBV in camelids. Vet. Rec. 170, 
603 
Alpacas (Vicugna pacos)  None 
recognised 
Detection of antibodies in 2/10. 
ID Screen Schmallenberg Virus 
Indirect Elisa (ID.vet). 
 
Azkur A, Albayrak H, Risvanli A, Pestil Z, Ozan E, Yılmaz O, 
Tonbak  S,  Cavunt  A,  Kadı  H,  Macun  H,  Acar  D,  Özenç  E, 
Alparslan S and Bulut H, 2013. Antibodies to Schmallenberg 
virus in domestic livestock in Turkey. Tropical Animal Health 
and  Production,  1-4.  Available  from 
http://dx.doi.org/10.1007/s11250-013-0415-2. 
Anatolian water buffalo   None 
recognised 
Detection of antibodies in 2 out of 
130 sampled 
 
The sera were screened by indirect 
ELISA (ID Screen® Schmallenberg 
virus indirect, IDvet Innovative 
Diagnostics), following the 
manufacturer‟s instructions. Test 
samples (S), positive (PC) and 
negative controls (NC) were run on 
each plate. Optical densities at a 
wavelength of 450 nm (OD) were 
determined, and results were 
calculated using an automated 
ELISA reader (BIOTEK ELX800). 
For each sample, the S/P percentage 
was calculated as follows: 
(ODsample−ODNC)/(ODPC−ODN
C)×100. Samples with an S/P% of 
≤50 % were considered negative, 
50–60  %  doubtful,  and  >60  % 
positive, respectively 
Wide area and temporal 
coverage,  but  sample 
may  not  be 
representative. 
Description  of  potential 
test  reaction  to  other 
Simbu  virus.  No  detail 
about study design. Schmallenberg virus: State of Art 
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Larska M, Krzysiak M, Smreczak M, Polak MP, Zmudzinski 
JF, 2013. First detection of Schmallenberg virus in elk (Alces 
alces)  indicating  infection  of  wildlife  in  Bialowieza  National 
Park  in  Poland,  Vet  J.  Aug  16.  pii:  S1090-0233(13)00388-2. 
doi: 10.1016/j.tvjl.2013.08.013. 
Elk  (Alces  alces),  bison 
(Bison bonasus) 
 
None 
recognised 
Elk calf (one  serum  sample  tested 
positive  by  RT-PCR,  negative 
indirect  ELISA).  Serum  samples 
collected from free-living bison (n 
= 60, 22 positive), wild red deer (n 
= 69, 15 positive), farmed red deer  
(n  =  24,  no  positive)  and  fallow 
deer (n = 16, no positive)  
No  details  are  given 
about  the  study  design, 
and  how  sample  were 
collected.  Samples 
collected  from  eight 
different locations. 
Barlow  A,  Green  P,  Banham  T,  Healy  N,  2013.  Serological 
confirmation of SBV infection in wild British deer. Vet Rec. 
Apr 20;172(16):429. doi: 10.1136/vr.f2438 
Red deer (Cervus elaphus), 
fallow deer (Dama dama) , 
roe  deer  (  Capreolus 
capreolus)  and  muntjac 
(Muntiacus reevesi)  
None 
recognised 
Red  deer  (5  positive  out  of  7), 
fallow  deer  (9  positive  and  1 
inconclusive out of 16), roe deer (8, 
all  negative)  and  muntjac  (1 
inconclusive out of 35) 
 
commercially available ELISA 
(IDScreen Schmallenberg Virus 
Indirect Antibody ELISA; ID-Vet). 
Results  of  sero-
surveillance  from  a 
short  period  from 
February 20 to March 6, 
2012.  Small  number  of 
samples  and  no  detail 
about study design. 
Chiari  M,  Sozzi  E,  Zanoni  M,  Alborali  LG,  Lavazza  A  and 
Cordioli  P,  2014.  Serosurvey  for  Schmallenberg  Virus  in 
Alpine  Wild  Ungulates.  Transboundary  and  Emerging 
Diseases, http://dx.doi.org/10.1111/tbed.12158. 
 
 
Red  deer  (Cervus 
elaphus)and  
Chamois  (Rupicapra 
rupicapra)  
None 
recognised 
Samples from several years (2007-
2013)  were  tested,  and  only 
samples  from  2012-2013  resulted 
positive (1 out of 6 chamois, 21 out 
of 52 red  deer) 
 
 All sera tested by serological SBV 
ELISA kit (ID Screen_ 
Schmallenberg Virus Competition, 
Multispecies; IDvet Innovative 
Diagnostics, Montpellier, France). 
All sera positive by ELISA were 
also positive by 
VNT. 
Sampling area with high 
red  deer  density,  but 
very  restrictive, 
potential  issues  with 
representativity.  Small 
number  of  samples  and 
no  detail  about  study 
design. Schmallenberg virus: State of Art 
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Linden  A,  Desmecht  D,  Volpe  R,  Wirtgen  M,  Gregoire  F, 
Pirson J, Paternostre J, Kleijnen D, Schirrmeier H, Beer M and 
Garigliany  M-M,  2012.  Epizootic  Spread  of  Schmallenberg 
Virus  among  Wild  Cervids,  Belgium,  Fall  2011.  Emerging 
Infectious  Diseases,  18,  2006-2008.  Available  from  <Go  to 
ISI>://MEDLINE:23171763. 
 
 
 Red deer(Cervus elaphus) 
and 
roe  deer  (Capreolus 
capreolus) 
None 
recognised 
Blood  samples  were  collected 
during post-mortem examination of 
313  red  deer  (seroprevalence 
40.5%, 95% CI 31.6%–49.5%)  and 
211  roe  deer  (seroprevalence 
45.9%, 95% CI 36.5%–55.2%) shot 
during the 2010 and 2011 hunting 
seasons. .  
 
IgG against the recombinant 
nucleoprotein 
of the emerging SBV was detected 
by using 
an ELISA kit (ID Screen 
Schmallenberg Virus Indirect, 
version 1; ID.vet Innovative 
Diagnostics, Montpellier, France). 
Results are expressed as 
percentages of the reference signal 
yielded by the positive control 
serum; serologic status is defined as 
negative (<60%), doubtful (60%–
70%), 
or positive (>70%). Neutralizing 
antibodies against SBV were sought 
as described (3) in subsets of roe 
deer serum (IgG-negative and IgG-
positive according to ELISA), and 
a linear relationship between 
percentages and reciprocal 
neutralizing titers was found 
Samples were randomly 
collected  during 
October–December 
from 35 hunting estates 
in 4 of the 5 provinces 
in  southern  Belgium, 
limited  information 
regarding study design. Schmallenberg virus: State of Art 
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Sailleau, C, Boogaerts, C, Meyrueix, A, Laloy, E, Bréard, E.,  
Viarouge, C.,  Desprat, A, Vitour, A, Doceul, V, Boucher, C, 
Zientara,  S.  and  Grandjean,  D,  2013.  Schmallenberg  Virus 
Infection  In  Dogs,  France,  2012. Emerg.  Infect.  Dis.  19:11. 
doi: 10.3201/eid1911.130464. 
Dogs (Canis domesticus)  Yes  Signs  of  ataxia,  exotropia,  a  head 
tilt,  and  stunted  growth  were 
observed  in  a  litter  of  5  puppies. 
Four  die  at  5  –  6  weeks,  blood 
sample  from  survivor  (age  of  3 
months) VNT as well as ID vet test 
were  performed  to  the  puppy  and 
the  mother,  showing  negative 
results  for  the  puppy  and  positive 
for  the  mother.  RT-PCR  was  also 
performed to the puppy, identifying 
it as positive 
The  study  used  several 
test  techniques  to 
scrutinize  the  suspected 
animals  adapting  the 
methods  in  order  to 
cope  with  the 
differentiation  between 
ruminants and canines. 
Wensman JJ, Blomqvist G, Hjort M, Holst BS, 2013. Presence 
of antibodies to Schmallenberg virus in a dog in Sweden, J Clin 
Microbiol. Aug;51(8):2802-3. doi: 10.1128/JCM.00877-13 
Dogs (Canis domesticus)  None 
recognised 
One positive female dog out of 86 
(sample  tested  with  IDvet  and 
confirmed  with  serum 
neutralization test) 
No details are given on 
how  the  animals  were 
selected  to  be  included 
in this study.  
Garigliany  MM,  Desmecht  D,  Bayrou  C,  Peeters  D,  No 
Serologic  Evidence  for  Emerging  Schmallenberg  Virus 
Infection in Dogs (Canis domesticus). Vector Borne Zoonotic 
Diseases 13(11), 830-833 doi: 10.1089/vbz.2012.1251.  
 Dogs (Canis domesticus)  None 
recognised 
IDvet results showed all 132 serum 
samples but one were negative, the 
last  being  classified  as  doubtful 
(S/P between 60 and 70%). Second 
generation  ELISA  confirmed  the 
results from IDvet test.  
No details are given on 
how  the  animals  were 
selected  to  be  included 
in this study.  
The study includes dogs 
with  potentially  high 
level  of  exposure  to 
SBV,  containing  three 
groups  according  to 
their exposure. Schmallenberg virus: State of Art 
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Laloy  Eve,  Emmanuel  Breard,  Corinne  Sailleau,  Cyril 
Viarouge,  Alexandra  Desprat,  Stéphan  Zientara,  François 
Klein,  Jean  Hars,  Sophie  Rossi.  2014.  Schmallenberg  Virus 
Infection among Red Deer, France, 2010- 2012. Emerg. Infect. 
Dis, 20, 131-134. 
Red deer  No 
reported 
Three tests were used. i-ELISA ID 
Screen  Schmallenberg  Virus 
Indirect,  Bicupule;  ID  Vet 
(S/P<60%,  negative;  S/P>70%, 
positive; and S/P 60–70%, doubtful 
result), c-ELISA; ELISA ID Screen 
Schmallenberg  Virus  Competitive; 
ID  Vet  (Positive  results  by  c-
ELISA  corresponded  to  a 
percentage  of  inhibition  (PI)  <50, 
doubtful  result  if  40>PI≤50,  and 
negative  when  PI  >50)  and 
seroneutralization  test  (SNT).  The 
two  ELISA  methods  exhibited  a 
92%  match  (449/486),  larger 
discrepancies  were  observed 
between  the  ELISA  tests  and  the 
SNT  results,  indicating  low 
sensitivity  and  specificity  for  the 
ELISA tests. 
The  study  used  several 
test  techniques  to 
scrutinize  the  samples. 
No details are given on 
how  the  samples  were 
selected. The three tests 
were only performed in 
23%  of  the  samples 
available  due  to 
bacterial  contamination 
or cytotoxicity. 
 